entity_type,gtopdb_id,name,abbreviation,systematic_name,url,class,families,uniprot_accessions,gene_symbols,gene_ids,ligand_pubchem_cid,ligand_pubchem_sid,smiles,inchi,inchikey;;
"Ligand,1772,clopidogrel (active metabolite),,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1772,Synthetic organic,,,,,10066813,135649894,COC(=O)[C@H](c1ccccc1Cl)N1CCC(/C(=C\C(=O)O)/C1)S,""InChI=1S/C16H18ClNO4S/c1-22-16(21)15(11-4-2-3-5-12(11)17)18-7-6-13(23)10(9-18)8-14(19)20/h2-5,8,13,15,23H,6-7,9H2,1H3,(H,19,20)/b10-8-/t13?,15-/m0/s1"",CWUDNVCEAAXNQA-AWGNNQSZSA-N,";;
"Ligand,5678,dasatinib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5678,Synthetic organic,,,,,3062316,178102305,OCCN1CCN(CC1)c1cc(nc(n1)C)Nc1ncc(s1)C(=O)Nc1c(C)cccc1Cl,""InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)"",ZBNZXTGUTAYRHI-UHFFFAOYSA-N,";;
"Ligand,6494,dabrafenib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6494,Synthetic organic,,,,,44462760,178103108,Nc1nccc(n1)c1sc(nc1c1cccc(c1F)NS(=O)(=O)c1c(F)cccc1F)C(C)(C)C,""InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)"",BFSMGDJOXZAERB-UHFFFAOYSA-N,";;
"Ligand,7045,dimethyl fumarate,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7045,Synthetic organic,,,,,637568,178103624,COC(=O)/C=C/C(=O)OC,""InChI=1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3/b4-3+"",LDCRTTXIJACKKU-ONEGZZNKSA-N,";;
"Ligand,5713,sunitinib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5713,Synthetic organic,,,,,5329102,178102339,CCN(CCNC(=O)c1c(C)[nH]c(c1C)/C=C/1\C(=O)Nc2c1cc(F)cc2)CC,""InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-"",WINHZLLDWRZWRT-ATVHPVEESA-N,";;
"Ligand,7469,ciclesonide,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7469,Synthetic organic,,,,,6918155,187051772,O=C(C(C)C)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@@H]1[C@]2(C)C[C@H](O)[C@H]2[C@H]1CCC1=CC(=O)C=C[C@]21C)C1CCCCC1,""InChI=1S/C32H44O7/c1-18(2)28(36)37-17-25(35)32-26(38-29(39-32)19-8-6-5-7-9-19)15-23-22-11-10-20-14-21(33)12-13-30(20,3)27(22)24(34)16-31(23,32)4/h12-14,18-19,22-24,26-27,29,34H,5-11,15-17H2,1-4H3/t22-,23-,24-,26+,27+,29+,30-,31-,32+/m0/s1"",LUKZNWIVRBCLON-GXOBDPJESA-N,";;
Target,2948,butyrophilin subfamily 3 member A1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2948,OtherProtein,Butyrophilin and butyrophilin-like proteins,Human:O00481,Human:BTN3A1,Human:1138,,,,,,;;
"Ligand,5688,ruxolitinib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5688,Synthetic organic,,,,,25126798,178102315,N#CC[C@@H](n1ncc(c1)c1ncnc2c1cc[nH]2)C1CCCC1,""InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1"",HFNKQEVNSGCOJV-OAHLLOKOSA-N,";;
"Ligand,5711,sorafenib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5711,Synthetic organic,,,,,216239,178102337,CNC(=O)c1nccc(c1)Oc1ccc(cc1)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl,""InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)"",MLDQJTXFUGDVEO-UHFFFAOYSA-N,";;
"Ligand,7239,metipranolol,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7239,Synthetic organic,,,,,31477,178103813,OC(COc1cc(C)c(c(c1C)C)OC(=O)C)CNC(C)C,""InChI=1S/C17H27NO4/c1-10(2)18-8-15(20)9-21-16-7-11(3)17(22-14(6)19)13(5)12(16)4/h7,10,15,18,20H,8-9H2,1-6H3"",BQIPXWYNLPYNHW-UHFFFAOYSA-N,";;
"Ligand,10510,carotegrast methyl,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10510,Synthetic organic,,,,,9872780,387065592,COC(=O)[C@@H](NC(=O)c1c(Cl)cccc1Cl)Cc1ccc(cc1)n1c(=O)c2cc(ccc2n(c1=O)C)N(C)C,""InChI=1S/C28H26Cl2N4O5/c1-32(2)18-12-13-23-19(15-18)26(36)34(28(38)33(23)3)17-10-8-16(9-11-17)14-22(27(37)39-4)31-25(35)24-20(29)6-5-7-21(24)30/h5-13,15,22H,14H2,1-4H3,(H,31,35)/t22-/m0/s1"",MMHHPKCJJIFLBQ-QFIPXVFZSA-N,";;
"Ligand,5687,imatinib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5687,Synthetic organic,,,,,5291,178102314,CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(c(c1)Nc1nccc(n1)c1cccnc1)C,""InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)"",KTUFNOKKBVMGRW-UHFFFAOYSA-N,";;
"Ligand,11748,baloxavir marboxil,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11748,Synthetic organic,,,,,124081896,458923783,COC(=O)OCOc1c2C(=O)N3CCOC[C@H]3N(n2ccc1=O)[C@H]1c2c(CSc3ccccc13)c(c(cc2)F)F,""InChI=1S/C27H23F2N3O7S/c1-36-27(35)39-14-38-25-19(33)8-9-31-24(25)26(34)30-10-11-37-12-21(30)32(31)23-15-6-7-18(28)22(29)17(15)13-40-20-5-3-2-4-16(20)23/h2-9,21,23H,10-14H2,1H3/t21-,23+/m1/s1"",RZVPBGBYGMDSBG-GGAORHGYSA-N,";;
"Ligand,7186,fenofibrate,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7186,Synthetic organic,,,,,3339,178103761,CC(OC(=O)C(Oc1ccc(cc1)C(=O)c1ccc(cc1)Cl)(C)C)C,""InChI=1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3"",YMTINGFKWWXKFG-UHFFFAOYSA-N,";;
"Ligand,5892,temsirolimus,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5892,Synthetic organic,,,,,6918289,178102515,CO[C@@H]1C[C@@H](CC[C@H]1OC(=O)C(CO)(CO)C)C[C@H]([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](OC)/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C1)C)/C)O)OC)C)C)/C)C,""InChI=1S/C56H87NO16/c1-33-17-13-12-14-18-34(2)45(68-9)29-41-22-20-39(7)56(67,73-41)51(63)52(64)57-24-16-15-19-42(57)53(65)71-46(30-43(60)35(3)26-38(6)49(62)50(70-11)48(61)37(5)25-33)36(4)27-40-21-23-44(47(28-40)69-10)72-54(66)55(8,31-58)32-59/h12-14,17-18,26,33,35-37,39-42,44-47,49-50,58-59,62,67H,15-16,19-25,27-32H2,1-11H3/b14-12+,17-13+,34-18+,38-26+/t33-,35-,36-,37-,39-,40+,41+,42+,44-,45+,46+,47-,49-,50+,56-/m1/s1"",CBPNZQVSJQDFBE-FUXHJELOSA-N,";;
"Ligand,5698,pazopanib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5698,Synthetic organic,,,,,10113978,178102325,CN(c1ccc2c(c1)nn(c2C)C)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N)C,""InChI=1S/C21H23N7O2S/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25)"",CUIHSIWYWATEQL-UHFFFAOYSA-N,";;
"Ligand,4941,gefitinib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4941,Synthetic organic,,,,,123631,178101639,COc1cc2ncnc(c2cc1OCCCN1CCOCC1)Nc1ccc(c(c1)Cl)F,""InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)"",XGALLCVXEZPNRQ-UHFFFAOYSA-N,";;
"Ligand,5893,vemurafenib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5893,Synthetic organic,,,,,42611257,178102516,CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(cn2)c1ccc(cc1)Cl)F,""InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)"",GPXBXXGIAQBQNI-UHFFFAOYSA-N,";;
"Ligand,2407,fingolimod,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2407,Synthetic organic,,,,,107970,135650261,CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N,""InChI=1S/C19H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/h9-12,21-22H,2-8,13-16,20H2,1H3"",KKGQTZUTZRNORY-UHFFFAOYSA-N,";;
"Ligand,7564,nepafenac,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7564,Synthetic organic,Non-steroidal anti-inflammatory ligands,,,,151075,223365900,NC(=O)Cc1cccc(c1N)C(=O)c1ccccc1,""InChI=1S/C15H14N2O2/c16-13(18)9-11-7-4-8-12(14(11)17)15(19)10-5-2-1-3-6-10/h1-8H,9,17H2,(H2,16,18)"",QEFAQIPZVLVERP-UHFFFAOYSA-N,";;
"Ligand,7451,tafluprost,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7451,Synthetic organic,,,,,9868491,187051754,CC(OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/C(COc1ccccc1)(F)F)O)C,""InChI=1S/C25H34F2O5/c1-18(2)32-24(30)13-9-4-3-8-12-20-21(23(29)16-22(20)28)14-15-25(26,27)17-31-19-10-6-5-7-11-19/h3,5-8,10-11,14-15,18,20-23,28-29H,4,9,12-13,16-17H2,1-2H3/b8-3-,15-14+/t20-,21-,22+,23-/m1/s1"",WSNODXPBBALQOF-VEJSHDCNSA-N,";;
"Ligand,9676,proguanil,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9676,Synthetic organic,Antimalarial ligands,,,,6178111,348353635,CC(N=C(/N=C(/Nc1ccc(cc1)Cl)\N)N)C,""InChI=1S/C11H16ClN5/c1-7(2)15-10(13)17-11(14)16-9-5-3-8(12)4-6-9/h3-7H,1-2H3,(H5,13,14,15,16,17)"",SSOLNOMRVKKSON-UHFFFAOYSA-N,";;
"Ligand,9262,LFM-A13,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9262,Synthetic organic,,,,,54676905,315661337,C/C(=C(/C(=O)Nc1cc(Br)ccc1Br)\C#N)/O,""InChI=1S/C11H8Br2N2O2/c1-6(16)8(5-14)11(17)15-10-4-7(12)2-3-9(10)13/h2-4,16H,1H3,(H,15,17)/b8-6-"",UVSVTDVJQAJIFG-VURMDHGXSA-N,";;
"Ligand,6844,teriflunomide,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6844,Synthetic organic,,,,,54684141,178103450,N#C/C(=C(/O)\C)/C(=O)Nc1ccc(cc1)C(F)(F)F,""InChI=1S/C12H9F3N2O2/c1-7(18)10(6-16)11(19)17-9-4-2-8(3-5-9)12(13,14)15/h2-5,18H,1H3,(H,17,19)/b10-7-"",UTNUDOFZCWSZMS-YFHOEESVSA-N,";;
"Ligand,7452,tafluprost acid,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7452,Synthetic organic,,,,,9978917,187051755,OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/C(COc1ccccc1)(F)F)O,""InChI=1S/C22H28F2O5/c23-22(24,15-29-16-8-4-3-5-9-16)13-12-18-17(19(25)14-20(18)26)10-6-1-2-7-11-21(27)28/h1,3-6,8-9,12-13,17-20,25-26H,2,7,10-11,14-15H2,(H,27,28)/b6-1-,13-12+/t17-,18-,19+,20-/m1/s1"",KIQXRQVVYTYYAZ-VKVYFNERSA-N,";;
"Ligand,6373,perindoprilat,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6373,Synthetic organic,,,,,72022,178102991,CCC[C@@H](C(=O)O)N[C@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O)C,""InChI=1S/C17H28N2O5/c1-3-6-12(16(21)22)18-10(2)15(20)19-13-8-5-4-7-11(13)9-14(19)17(23)24/h10-14,18H,3-9H2,1-2H3,(H,21,22)(H,23,24)/t10-,11-,12-,13-,14-/m0/s1"",ODAIHABQVKJNIY-PEDHHIEDSA-N,";;
"Ligand,4306,salicylic acid,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4306,Natural product,,,,,338,178101123,OC(=O)c1ccccc1O,""InChI=1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10)"",YGSDEFSMJLZEOE-UHFFFAOYSA-N,";;
"Ligand,7562,prasugrel,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7562,Synthetic organic,,,,,6918456,223365898,CC(=O)Oc1sc2c(c1)CN(CC2)C(c1ccccc1F)C(=O)C1CC1,""InChI=1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3"",DTGLZDAWLRGWQN-UHFFFAOYSA-N,";;
"Ligand,12211,LY3023703,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12211,Synthetic organic,,,,,71059525,472319331,Cc1c(nc([nH]1)NC(=O)c1c(ncc(c1)CNC(=O)C(C)C)C(F)F)c1ccc(cc1)C(F)(F)F,""InChI=1S/C23H22F5N5O2/c1-11(2)20(34)30-10-13-8-16(18(19(24)25)29-9-13)21(35)33-22-31-12(3)17(32-22)14-4-6-15(7-5-14)23(26,27)28/h4-9,11,19H,10H2,1-3H3,(H,30,34)(H2,31,32,33,35)"",BZYSILFNUIGABU-UHFFFAOYSA-N,";;
"Ligand,6350,quinapril,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6350,Synthetic organic,,,,,54892,178102968,CCOC(=O)[C@@H](N[C@H](C(=O)N1Cc2ccccc2C[C@H]1C(=O)O)C)CCc1ccccc1,""InChI=1S/C25H30N2O5/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30)/t17-,21-,22-/m0/s1"",JSDRRTOADPPCHY-HSQYWUDLSA-N,";;
"Ligand,6339,ramipril,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6339,Synthetic organic,,,,,5362129,178102957,CCOC(=O)[C@@H](N[C@H](C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(=O)O)C)CCc1ccccc1,""InChI=1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1"",HDACQVRGBOVJII-JBDAPHQKSA-N,";;
"Ligand,11027,oleuropein,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11027,Natural product,,,,,5281544,405560468,OC[C@H]1O[C@@H](O[C@@H]2OC=C([C@H](/C/2=C\C)CC(=O)OCCc2ccc(c(c2)O)O)C(=O)OC)[C@@H]([C@H]([C@@H]1O)O)O,""InChI=1S/C25H32O13/c1-3-13-14(9-19(29)35-7-6-12-4-5-16(27)17(28)8-12)15(23(33)34-2)11-36-24(13)38-25-22(32)21(31)20(30)18(10-26)37-25/h3-5,8,11,14,18,20-22,24-28,30-32H,6-7,9-10H2,1-2H3/b13-3+/t14-,18+,20+,21-,22+,24-,25-/m0/s1"",RFWGABANNQMHMZ-ZCHJGGQASA-N,";;
"Ligand,11629,famciclovir,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11629,Synthetic organic,,,,,3324,442878663,CC(=O)OCC(CCn1cnc2c1nc(N)nc2)COC(=O)C,""InChI=1S/C14H19N5O4/c1-9(20)22-6-11(7-23-10(2)21)3-4-19-8-17-12-5-16-14(15)18-13(12)19/h5,8,11H,3-4,6-7H2,1-2H3,(H2,15,16,18)"",GGXKWVWZWMLJEH-UHFFFAOYSA-N,";;
"Ligand,10525,diroximel fumarate,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10525,Synthetic organic,,,,,73330464,387065607,COC(=O)/C=C/C(=O)OCCN1C(=O)CCC1=O,""InChI=1S/C11H13NO6/c1-17-10(15)4-5-11(16)18-7-6-12-8(13)2-3-9(12)14/h4-5H,2-3,6-7H2,1H3/b5-4+"",YIMYDTCOUQIDMT-SNAWJCMRSA-N,";;
"Ligand,11654,racecadotril,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11654,Synthetic organic,,,,,107751,442878680,CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1,""InChI=1S/C21H23NO4S/c1-16(23)27-15-19(12-17-8-4-2-5-9-17)21(25)22-13-20(24)26-14-18-10-6-3-7-11-18/h2-11,19H,12-15H2,1H3,(H,22,25)"",ODUOJXZPIYUATO-UHFFFAOYSA-N,";;
Target,345,IP receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=345,GPCR,Prostanoid receptors,Human:P43119|Mouse:P43252|Rat:P43253,Human:PTGIR|Mouse:Ptgir|Rat:Ptgir,Human:9602|Mouse:MGI:99535|Rat:1310890,,,,,,;;
Target,337,PrRP receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=337,GPCR,Prolactin-releasing peptide receptor,Human:P49683|Mouse:Q6VMN6|Rat:Q64121,Human:PRLHR|Mouse:Prlhr|Rat:Prlhr,Human:4464|Mouse:MGI:2135956|Rat:71037,,,,,,;;
Target,154,<i>MRGPRF</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=154,GPCR,Class A Orphans,Human:Q96AM1|Mouse:Q8VCJ6|Rat:P23749,Human:MRGPRF|Mouse:Mrgprf|Rat:Mrgprf,Human:24828|Mouse:MGI:2384823|Rat:708478,,,,,,;;
Target,2970,epoxide hydrolase 2,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2970,Enzyme,Hydrolases,Human:P34913|Mouse:P34914|Rat:P80299,Human:EPHX2|Mouse:Ephx2|Rat:Ephx2,Human:3402|Mouse:MGI:99500|Rat:620732,,,,,,;;
Family introduction,104,Lanosterol biosynthesis pathway,,,http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=104,Enzyme,,,,,,,,,,;;
"Ligand,9610,CBS-3595,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9610,Synthetic organic,,,,,10450926,340590240,CSc1nc(c(n1C)c1ccnc(c1)NC(=O)C)c1ccc(cc1)F,""InChI=1S/C18H17FN4OS/c1-11(24)21-15-10-13(8-9-20-15)17-16(22-18(25-3)23(17)2)12-4-6-14(19)7-5-12/h4-10H,1-3H3,(H,20,21,24)"",CJKGORBZVWDVRY-UHFFFAOYSA-N,";;
Family,154,ABCD subfamily of peroxisomal ABC transporters,,,http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=154,Transporter,,,,,,,,,,;;
Family introduction,64,Trace amine receptor,,,http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=64,GPCR,,,,,,,,,,;;
Family introduction,79,Two-pore domain potassium channels  (K<sub>2P</sub>),,,http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=79,VGIC,,,,,,,,,,;;
"Ligand,10413,RIPK2 inhibitor 3,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10413,Synthetic organic,,,,,73386708,385612173,OP(=O)(OCCOc1cc2ncnc(c2cc1S(=O)(=O)C(C)(C)C)Nc1ccc2c(c1)ncs2)O,""InChI=1S/C21H23N4O7PS2/c1-21(2,3)35(29,30)19-9-14-15(10-17(19)31-6-7-32-33(26,27)28)22-11-23-20(14)25-13-4-5-18-16(8-13)24-12-34-18/h4-5,8-12H,6-7H2,1-3H3,(H,22,23,25)(H2,26,27,28)"",MJLYDVMFNHZMLV-UHFFFAOYSA-N,";;
"Ligand,5692,lapatinib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5692,Synthetic organic,,,,,208908,178102319,Fc1cccc(c1)COc1ccc(cc1Cl)Nc1ncnc2c1cc(cc2)c1ccc(o1)CNCCS(=O)(=O)C,""InChI=1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35)"",BCFGMOOMADDAQU-UHFFFAOYSA-N,";;
"Ligand,5677,tofacitinib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5677,Synthetic organic,,,,,9926791,178102304,N#CCC(=O)N1CC[C@H]([C@H](C1)N(c1ncnc2c1cc[nH]2)C)C,""InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1"",UJLAWZDWDVHWOW-YPMHNXCESA-N,";;
"Ligand,5889,everolimus,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5889,Synthetic organic,,,,,6442177,178102512,OCCO[C@@H]1CC[C@H](C[C@H]1OC)C[C@H]([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](OC)/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C1)C)/C)O)OC)C)C)/C)C,""InChI=1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1"",HKVAMNSJSFKALM-GKUWKFKPSA-N,";;
"Ligand,10498,compound 8 [PMID: 25898023],,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10498,Synthetic organic,,,,,71283262,387065580,NCc1ccc(cc1c1cccc(c1)C(=O)Nc1ccc(cc1)C(=O)OC)C(=O)Nc1ccncc1F,""InChI=1S/C28H23FN4O4/c1-37-28(36)17-7-9-22(10-8-17)32-26(34)19-4-2-3-18(13-19)23-14-20(5-6-21(23)15-30)27(35)33-25-11-12-31-16-24(25)29/h2-14,16H,15,30H2,1H3,(H,32,34)(H,31,33,35)"",MXWDBTLNBKIMEX-UHFFFAOYSA-N,";;
"Ligand,11264,enoxolone,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11264,Synthetic organic,,,,,10114,434321699,O=C1C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@]2([C@]2([C@H]1[C@@]1(C)CC[C@@H](C([C@@H]1CC2)(C)C)O)C)C)C(=O)O,""InChI=1S/C30H46O4/c1-25(2)21-8-11-30(7)23(28(21,5)10-9-22(25)32)20(31)16-18-19-17-27(4,24(33)34)13-12-26(19,3)14-15-29(18,30)6/h16,19,21-23,32H,8-15,17H2,1-7H3,(H,33,34)/t19-,21-,22-,23+,26+,27-,28-,29+,30+/m0/s1"",MPDGHEJMBKOTSU-YKLVYJNSSA-N,";;
"Ligand,9939,dimethyl itaconate,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9939,Synthetic organic,,,,,69240,363894233,COC(=O)CC(=C)C(=O)OC,""InChI=1S/C7H10O4/c1-5(7(9)11-3)4-6(8)10-2/h1,4H2,2-3H3"",ZWWQRMFIZFPUAA-UHFFFAOYSA-N,";;
;;
Target,3174,Plasmodium falciparum acetyl-CoA synthetase,PfACS,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3174,OtherProtein,Other antimalarial targets,Plasmodium falciparum 3D7:C6KTB4,Plasmodium falciparum 3D7:ACAS,Plasmodium falciparum 3D7:PF3D7_0627800,,,,,,;;
Target,1385,5-LOX,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1385,Enzyme,Lipoxygenases,Human:P09917|Mouse:P48999|Rat:P12527,Human:ALOX5|Mouse:Alox5|Rat:Alox5,Human:435|Mouse:MGI:87999|Rat:2096,,,,,,;;
"Target,2887,""tryptophan 2,3-dioxygenase"",TDO2,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2887,Enzyme,1.13.11.- Dioxygenases,Human:P48775|Mouse:P48776|Rat:P21643,Human:TDO2|Mouse:Tdo2|Rat:Tdo2,Human:11708|Mouse:MGI:1928486|Rat:68370,,,,,,";;
"Target,2829,""indoleamine 2,3-dioxygenase 1"",IDO1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2829,Enzyme,1.13.11.- Dioxygenases,Human:P14902|Mouse:P28776|Rat:Q9ERD9,Human:IDO1|Mouse:Ido1|Rat:Ido1,Human:6059|Mouse:MGI:96416|Rat:619989,,,,,,";;
Target,226,FFA2 receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=226,GPCR,Free fatty acid receptors,Human:O15552|Mouse:Q8VCK6|Rat:Q76EI6,Human:FFAR2|Mouse:Ffar2|Rat:Ffar2,Human:4501|Mouse:MGI:2441731|Rat:1359614,,,,,,;;
Target,3018,aconitate decarboxylase 1,IRG1,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3018,Enzyme,Itaconate biosynthesis,Human:A6NK06|Mouse:P54987,Human:ACOD1|Mouse:Acod1|Rat:Acod1,Human:33904|Mouse:MGI:103206|Rat:1563454,,,,,,;;
Target,485,TRPA1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=485,VGIC,Transient Receptor Potential channels (TRP),Human:O75762|Mouse:Q8BLA8|Rat:Q6RI86,Human:TRPA1|Mouse:Trpa1|Rat:Trpa1,Human:497|Mouse:MGI:3522699|Rat:1303284,,,,,,;;
Target,295,mGlu<sub>7</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=295,GPCR,Metabotropic glutamate receptors,Human:Q14831|Mouse:Q68ED2|Rat:P35400,Human:GRM7|Mouse:Grm7|Rat:Grm7,Human:4599|Mouse:MGI:1351344|Rat:619857,,,,,,;;
Target,599,RAR-related orphan receptor-&beta;,,NR1F2,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=599,NHR,1F. Retinoic acid-related orphans,Human:Q92753|Mouse:Q8R1B8|Rat:P45446,Human:RORB|Mouse:Rorb|Rat:Rorb,Human:10259|Mouse:MGI:1343464|Rat:1306778,,,,,,;
Target,593,Peroxisome proliferator-activated receptor-&alpha;,,NR1C1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=593,NHR,1C. Peroxisome proliferator-activated receptors,Human:Q07869|Mouse:P23204|Rat:P37230,Human:PPARA|Mouse:Ppara|Rat:Ppara,Human:9232|Mouse:MGI:104740|Rat:3369,,,,,,;
Target,157,<i>MRGPRX2</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=157,GPCR,Class A Orphans,Human:Q96LB1,Human:MRGPRX2,Human:17983,,,,,,;;
Target,151,<i>MAS1L</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=151,GPCR,Class A Orphans,Human:P35410,Human:MAS1L,Human:13961,,,,,,;;
Target,98,<i>GPR31</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=98,GPCR,Class A Orphans,Human:O00270|Mouse:F8VQN3,Human:GPR31|Mouse:Gpr31c|Rat:Gpr31,Human:4486|Mouse:MGI:1354371|Rat:1305187,,,,,,;;
"Target,89,<i>GPR18</i>,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=89,GPCR,""GPR18, GPR55 and GPR119"",Human:Q14330|Mouse:Q8K1Z6|Rat:A1A5S3,Human:GPR18|Mouse:Gpr18|Rat:Gpr18,Human:4472|Mouse:MGI:107859|Rat:1304889,,,,,,";;
Target,625,Glucocorticoid receptor,,NR3C1,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=625,NHR,3C. 3-Ketosteroid receptors,Human:P04150|Mouse:P06537|Rat:P06536,Human:NR3C1|Mouse:Nr3c1|Rat:Nr3c1,Human:7978|Mouse:MGI:95824|Rat:2741,,,,,,;;
Target,344,FP receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=344,GPCR,Prostanoid receptors,Human:P43088|Mouse:P43117|Rat:P43118,Human:PTGFR|Mouse:Ptgfr|Rat:Ptgfr,Human:9600|Mouse:MGI:97796|Rat:3436,,,,,,;;
Target,341,EP<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=341,GPCR,Prostanoid receptors,Human:P43116|Mouse:Q62053|Rat:Q62928,Human:PTGER2|Mouse:Ptger2|Rat:Ptger2,Human:9594|Mouse:MGI:97794|Rat:620020,,,,,,;;
Target,339,DP<sub>2</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=339,GPCR,Prostanoid receptors,Human:Q9Y5Y4|Mouse:Q9Z2J6|Rat:Q6XKD3,Human:PTGDR2|Mouse:Ptgdr2|Rat:Ptgdr2,Human:4502|Mouse:MGI:1330275|Rat:1311986,,,,,,;;
Target,31,C3a receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=31,GPCR,Complement peptide receptors,Human:Q16581|Mouse:O09047|Rat:O55197,Human:C3AR1|Mouse:C3ar1|Rat:C3ar1,Human:1319|Mouse:MGI:1097680|Rat:620537,,,,,,;;
Target,41,B<sub>1</sub> receptor,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=41,GPCR,Bradykinin receptors,Human:P46663|Mouse:Q61125|Rat:P97583,Human:BDKRB1|Mouse:Bdkrb1|Rat:Bdkrb1,Human:1029|Mouse:MGI:88144|Rat:620401,,,,,,;;
"Ligand,5276,sapropterin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5276,Metabolite,,,,,135398654,178101959,C[C@@H]([C@@H]([C@H]1CNc2c(N1)c(=O)[nH]c(n2)N)O)O,""InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,4+,6-/m0/s1"",FNKQXYHWGSIFBK-RPDRRWSUSA-N,";;
"Ligand,9038,PF-04859989,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9038,Synthetic organic,,,,,22868923,315661123,O=C1[C@@H](N)Cc2c(N1O)cccc2,""InChI=1S/C9H10N2O2/c10-7-5-6-3-1-2-4-8(6)11(13)9(7)12/h1-4,7,13H,5,10H2/t7-/m0/s1"",HYTRYTZFJVVZAF-ZETCQYMHSA-N,";;
"Ligand,7682,atecegatran metoxil,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7682,Synthetic organic,,,,,9961205,223366017,CO/N=C(/c1ccc(cc1)CNC(=O)[C@@H]1CCN1C(=O)[C@@H](c1cc(Cl)cc(c1)OC(F)F)O)\N,""InChI=1S/C22H23ClF2N4O5/c1-33-28-19(26)13-4-2-12(3-5-13)11-27-20(31)17-6-7-29(17)21(32)18(30)14-8-15(23)10-16(9-14)34-22(24)25/h2-5,8-10,17-18,22,30H,6-7,11H2,1H3,(H2,26,28)(H,27,31)/t17-,18+/m0/s1"",XSNMGLZVFNDDPW-ZWKOTPCHSA-N,";;
"Ligand,6497,upamostat,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6497,Synthetic organic,,,,,56843330,178103111,CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NS(=O)(=O)c1c(cc(cc1C(C)C)C(C)C)C(C)C)Cc1cccc(c1)/C=N/NO,""InChI=1S/C32H47N5O6S/c1-8-43-32(39)37-14-12-36(13-15-37)31(38)29(17-24-10-9-11-25(16-24)20-33-35-40)34-44(41,42)30-27(22(4)5)18-26(21(2)3)19-28(30)23(6)7/h9-11,16,18-23,29,34-35,40H,8,12-15,17H2,1-7H3/b33-20+/t29-/m0/s1"",CYCFEEXTLQGJEL-XEOXDSMQSA-N,";;
"Ligand,9635,latanoprostene bunod,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9635,Synthetic organic,,,,,11156438,340590265,O[C@@H](CCc1ccccc1)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)OCCCCO[N+](=O)[O-])O,""InChI=1S/C27H41NO8/c29-22(15-14-21-10-4-3-5-11-21)16-17-24-23(25(30)20-26(24)31)12-6-1-2-7-13-27(32)35-18-8-9-19-36-28(33)34/h1,3-6,10-11,22-26,29-31H,2,7-9,12-20H2/b6-1-/t22-,23+,24+,25-,26+/m0/s1"",LOVMMUBRQUFEAH-UIEAZXIASA-N,";;
"Ligand,7552,selexipag,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7552,Synthetic organic,,,,,9913767,223365888,O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C,""InChI=1S/C26H32N4O4S/c1-20(2)30(16-10-11-17-34-19-24(31)29-35(3,32)33)23-18-27-25(21-12-6-4-7-13-21)26(28-23)22-14-8-5-9-15-22/h4-9,12-15,18,20H,10-11,16-17,19H2,1-3H3,(H,29,31)"",QXWZQTURMXZVHJ-UHFFFAOYSA-N,";;
"Ligand,7357,ABT-384,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7357,Synthetic organic,,,,,11670435,178103929,O=C(C(N1CCN(CC1)c1ccc(cn1)C(F)(F)F)(C)C)NC1C2CC3CC1CC(C2)(C3)C(=O)N,""InChI=1S/C25H34F3N5O2/c1-23(2,33-7-5-32(6-8-33)19-4-3-18(14-30-19)25(26,27)28)22(35)31-20-16-9-15-10-17(20)13-24(11-15,12-16)21(29)34/h3-4,14-17,20H,5-13H2,1-2H3,(H2,29,34)(H,31,35)"",CLHMYBJIOZXCEX-UHFFFAOYSA-N,";;
"Ligand,9319,amiselimod,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9319,Synthetic organic,,,,,16129483,318164838,CCCCCCCOc1ccc(cc1C(F)(F)F)CCC(CO)(CO)N,""InChI=1S/C19H30F3NO3/c1-2-3-4-5-6-11-26-17-8-7-15(12-16(17)19(20,21)22)9-10-18(23,13-24)14-25/h7-8,12,24-25H,2-6,9-11,13-14,23H2,1H3"",JVCPIJKPAKAIIP-UHFFFAOYSA-N,";;
"Ligand,103,zotepine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103,Synthetic organic,,,,,5736,135651367,CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C,""InChI=1S/C18H18ClNOS/c1-20(2)9-10-21-16-11-13-5-3-4-6-17(13)22-18-8-7-14(19)12-15(16)18/h3-8,11-12H,9-10H2,1-2H3"",HDOZVRUNCMBHFH-UHFFFAOYSA-N,";;
"Ligand,6462,zofenopril,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6462,Synthetic organic,,,,,92400,178103076,O=C(N1C[C@H](C[C@H]1C(=O)O)Sc1ccccc1)[C@@H](CSC(=O)c1ccccc1)C,""InChI=1S/C22H23NO4S2/c1-15(14-28-22(27)16-8-4-2-5-9-16)20(24)23-13-18(12-19(23)21(25)26)29-17-10-6-3-7-11-17/h2-11,15,18-19H,12-14H2,1H3,(H,25,26)/t15-,18+,19+/m1/s1"",IAIDUHCBNLFXEF-MNEFBYGVSA-N,";;
"Ligand,6381,ximelagatran,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6381,Synthetic organic,,,,,9574101,178102999,CCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(cc1)/C(=N/O)/N)C1CCCCC1,""InChI=1S/C24H35N5O5/c1-2-34-20(30)15-26-21(17-6-4-3-5-7-17)24(32)29-13-12-19(29)23(31)27-14-16-8-10-18(11-9-16)22(25)28-33/h8-11,17,19,21,26,33H,2-7,12-15H2,1H3,(H2,25,28)(H,27,31)/t19-,21+/m0/s1"",ZXIBCJHYVWYIKI-PZJWPPBQSA-N,";;
"Ligand,4816,folinic acid,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4816,Synthetic organic,,,,,135403648,178101518,O=CN1C(CNc2ccc(cc2)C(=O)N[C@H](C(=O)O)CCC(=O)O)CNc2c1c(=O)nc([nH]2)N,""InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12?,13-/m0/s1"",VVIAGPKUTFNRDU-ABLWVSNPSA-N,";;
"Ligand,9770,tepilamide fumarate,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9770,Synthetic organic,,,,,46179632,354702243,CCN(C(=O)COC(=O)/C=C/C(=O)OC)CC,""InChI=1S/C11H17NO5/c1-4-12(5-2)9(13)8-17-11(15)7-6-10(14)16-3/h6-7H,4-5,8H2,1-3H3/b7-6+"",AKUGRXRLHCCENI-VOTSOKGWSA-N,";;
"Ligand,10608,metamizole,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10608,Synthetic organic,,,,,3111,404859055,CN(c1c(C)n(n(c1=O)c1ccccc1)C)CS(=O)(=O)O,""InChI=1S/C13H17N3O4S/c1-10-12(14(2)9-21(18,19)20)13(17)16(15(10)3)11-7-5-4-6-8-11/h4-8H,9H2,1-3H3,(H,18,19,20)"",LVWZTYCIRDMTEY-UHFFFAOYSA-N,";;
"Ligand,11736,temocapril,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11736,Synthetic organic,,,,,443874,458923771,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CS[C@@H](CN(C1=O)CC(=O)O)c1cccs1,""InChI=1S/C23H28N2O5S2/c1-2-30-23(29)17(11-10-16-7-4-3-5-8-16)24-18-15-32-20(19-9-6-12-31-19)13-25(22(18)28)14-21(26)27/h3-9,12,17-18,20,24H,2,10-11,13-15H2,1H3,(H,26,27)/t17-,18-,20-/m0/s1"",FIQOFIRCTOWDOW-BJLQDIEVSA-N,";;
"Ligand,11569,balsalazide,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11569,Synthetic organic,,,,,54585,441604941,OC(=O)CCNC(=O)c1ccc(cc1)N=Nc1ccc(c(c1)C(=O)O)O,""InChI=1S/C17H15N3O6/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26)"",IPOKCKJONYRRHP-UHFFFAOYSA-N,";;
"Ligand,11287,efavirenz,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11287,Synthetic organic,,,,,64139,434321722,FC([C@@]1(C#CC2CC2)OC(=O)Nc2c1cc(Cl)cc2)(F)F,""InChI=1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)/t13-/m0/s1"",XPOQHMRABVBWPR-ZDUSSCGKSA-N,";;
"Ligand,11135,elafibranor,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11135,Synthetic organic,,,,,9864881,434122195,CSc1ccc(cc1)C(=O)/C=C/c1cc(C)c(c(c1)C)OC(C(=O)O)(C)C,""InChI=1S/C22H24O4S/c1-14-12-16(13-15(2)20(14)26-22(3,4)21(24)25)6-11-19(23)17-7-9-18(27-5)10-8-17/h6-13H,1-5H3,(H,24,25)/b11-6+"",AFLFKFHDSCQHOL-IZZDOVSWSA-N,";;
"Ligand,10613,reproxalap,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10613,Synthetic organic,,,,,16088030,404859060,Clc1ccc2c(c1)cc(c(n2)C(O)(C)C)N,""InChI=1S/C12H13ClN2O/c1-12(2,16)11-9(14)6-7-5-8(13)3-4-10(7)15-11/h3-6,16H,14H2,1-2H3"",GUHFUVLKYSQIOQ-UHFFFAOYSA-N,";;
"Ligand,10372,compound 14 [PMID: 30925062],,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10372,Synthetic organic,,,,,16618023,384403652,CC1CCc2c(C1)sc1c2c(nc(n1)c1cccnc1)N1CCN(CC1)C(c1ccccc1)C(=O)N,""InChI=1S/C28H30N6OS/c1-18-9-10-21-22(16-18)36-28-23(21)27(31-26(32-28)20-8-5-11-30-17-20)34-14-12-33(13-15-34)24(25(29)35)19-6-3-2-4-7-19/h2-8,11,17-18,24H,9-10,12-16H2,1H3,(H2,29,35)"",QAWHHEOBNCCSJP-UHFFFAOYSA-N,";;
"Ligand,8463,amelubant,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8463,Synthetic organic,,,,,60096302,252166673,CCOC(=O)NC(=N)c1ccc(cc1)OCc1cccc(c1)COc1ccc(cc1)C(c1ccc(cc1)O)(C)C,""InChI=1S/C33H34N2O5/c1-4-38-32(37)35-31(34)25-8-16-29(17-9-25)39-21-23-6-5-7-24(20-23)22-40-30-18-12-27(13-19-30)33(2,3)26-10-14-28(36)15-11-26/h5-20,36H,4,21-22H2,1-3H3,(H2,34,35,37)"",SBVYURPQULDJTI-UHFFFAOYSA-N,";;
"Ligand,4920,erlotinib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4920,Synthetic organic,,,,,176870,178101619,COCCOc1cc2c(ncnc2cc1OCCOC)Nc1cccc(c1)C#C,""InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)"",AAKJLRGGTJKAMG-UHFFFAOYSA-N,";;
"Ligand,5659,axitinib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5659,Synthetic organic,,,,,6450551,178102287,CNC(=O)c1ccccc1Sc1ccc2c(c1)[nH]nc2/C=C/c1ccccn1,""InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+"",RITAVMQDGBJQJZ-FMIVXFBMSA-N,";;
"Ligand,5891,regorafenib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5891,Synthetic organic,,,,,11167602,178102514,CNC(=O)c1nccc(c1)Oc1ccc(c(c1)F)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl,""InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)"",FNHKPVJBJVTLMP-UHFFFAOYSA-N,";;
"Ligand,6391,bortezomib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6391,Synthetic organic,Antimalarial ligands,,,,387447,178103007,CC(C[C@@H](B(O)O)NC(=O)[C@@H](NC(=O)c1cnccn1)Cc1ccccc1)C,""InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1"",GXJABQQUPOEUTA-RDJZCZTQSA-N,";;
"Ligand,5697,nilotinib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5697,Synthetic organic,,,,,644241,178102324,Cc1ncn(c1)c1cc(NC(=O)c2ccc(c(c2)Nc2nccc(n2)c2cccnc2)C)cc(c1)C(F)(F)F,""InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)"",HHZIURLSWUIHRB-UHFFFAOYSA-N,";;
"Ligand,5717,vandetanib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5717,Synthetic organic,,,,,3081361,178102343,COc1cc2c(ncnc2cc1OCC1CCN(CC1)C)Nc1ccc(cc1F)Br,""InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)"",UHTHHESEBZOYNR-UHFFFAOYSA-N,";;
"Ligand,5710,bosutinib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5710,Synthetic organic,,,,,5328940,178102336,COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N,""InChI=1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)"",UBPYILGKFZZVDX-UHFFFAOYSA-N,";;
"Ligand,5667,afatinib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5667,Synthetic organic,,,,,10184653,178102295,CN(C/C=C/C(=O)Nc1cc2c(ncnc2cc1O[C@@H]1COCC1)Nc1ccc(c(c1)Cl)F)C,""InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1"",ULXXDDBFHOBEHA-CWDCEQMOSA-N,";;
"Ligand,4825,zidovudine,AZT,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4825,Synthetic organic,,,,,35370,178101527,OC[C@H]1O[C@H](C[C@@H]1N=[N+]=[N-])n1cc(C)c(=O)[nH]c1=O,""InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1"",HBOMLICNUCNMMY-XLPZGREQSA-N,";;
"Ligand,7610,carisoprodol,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7610,Synthetic organic,,,,,2576,223365945,CCCC(COC(=O)N)(COC(=O)NC(C)C)C,""InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16)"",OFZCIYFFPZCNJE-UHFFFAOYSA-N,";;
"Ligand,7600,isotretinoin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7600,Synthetic organic,,,,,5282379,223365935,C/C(=C\C=C\C(=C/C(=O)O)\C)/C=C/C1=C(C)CCCC1(C)C,""InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14-"",SHGAZHPCJJPHSC-XFYACQKRSA-N,";;
"Ligand,7551,lofepramine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7551,Synthetic organic,,,,,3947,223365887,CN(CC(=O)c1ccc(cc1)Cl)CCCN1c2ccccc2CCc2c1cccc2,""InChI=1S/C26H27ClN2O/c1-28(19-26(30)22-13-15-23(27)16-14-22)17-6-18-29-24-9-4-2-7-20(24)11-12-21-8-3-5-10-25(21)29/h2-5,7-10,13-16H,6,11-12,17-19H2,1H3"",SAPNXPWPAUFAJU-UHFFFAOYSA-N,";;
"Ligand,7623,fosaprepitant,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7623,Synthetic organic,,,,,135413538,223365958,Fc1ccc(cc1)[C@H]1[C@H](OCCN1Cc1nc(=O)n([nH]1)P(=O)(O)O)O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C,""InChI=1S/C23H22F7N4O6P/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)40-20-19(13-2-4-17(24)5-3-13)33(6-7-39-20)11-18-31-21(35)34(32-18)41(36,37)38/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H,31,32,35)(H2,36,37,38)/t12-,19+,20-/m1/s1"",BARDROPHSZEBKC-OITMNORJSA-N,";;
"Ligand,6367,perindopril,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6367,Synthetic organic,,,,,107807,178102985,CCC[C@@H](C(=O)OCC)N[C@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O)C,""InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13-,14-,15-,16-/m0/s1"",IPVQLZZIHOAWMC-QXKUPLGCSA-N,";;
"Ligand,7254,oxcarbazepine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7254,Synthetic organic,,,,,34312,178103828,O=C1Cc2ccccc2N(c2c1cccc2)C(=N)O,""InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)"",CTRLABGOLIVAIY-UHFFFAOYSA-N,";;
"Ligand,6825,leflunomide,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6825,Synthetic organic,,,,,3899,178103431,O=C(c1cnoc1C)Nc1ccc(cc1)C(F)(F)F,""InChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18)"",VHOGYURTWQBHIL-UHFFFAOYSA-N,";;
"Ligand,4786,S-adenosyl methionine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4786,Metabolite,,,,,34756,178101488,C[S+](C[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N)CC[C@@H](C(=O)O)N,""InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/p+1/t7-,8+,10+,11+,14+,27?/m0/s1"",MEFKEPWMEQBLKI-AIRLBKTGSA-O,";;
"Ligand,4802,fludarabine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4802,Synthetic organic,,,,,657237,178101504,OC[C@H]1O[C@H]([C@H]([C@@H]1O)O)n1cnc2c1nc(F)nc2N,""InChI=1S/C10H12FN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6+,9-/m1/s1"",HBUBKKRHXORPQB-FJFJXFQQSA-N,";;
"Ligand,8480,phenylbutyrate,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8480,Synthetic organic,,,,,4775,252166688,OC(=O)CCCc1ccccc1,""InChI=1S/C10H12O2/c11-10(12)8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H,11,12)"",OBKXEAXTFZPCHS-UHFFFAOYSA-N,";;
"Ligand,7350,eslicarbazepine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7350,Synthetic organic,,,,,9881504,178103922,O[C@H]1Cc2ccccc2N(c2c1cccc2)C(=O)N,""InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1"",BMPDWHIDQYTSHX-AWEZNQCLSA-N,";;
"Ligand,551,carvedilol,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=551,Synthetic organic,,,,,2585,135650057,COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O,""InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3"",OGHNVEJMJSYVRP-UHFFFAOYSA-N,";;
"Ligand,6453,trandolapril,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6453,Synthetic organic,,,,,5484727,178103069,CCOC(=O)[C@@H](N[C@H](C(=O)N1[C@H]2CCCC[C@@H]2C[C@H]1C(=O)O)C)CCc1ccccc1,""InChI=1S/C24H34N2O5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29)/t16-,18+,19-,20-,21-/m0/s1"",VXFJYXUZANRPDJ-WTNASJBWSA-N,";;
"Ligand,2635,T<sub>4</sub>,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2635,Metabolite,,,,,5819,135651574,OC(=O)[C@H](Cc1cc(I)c(c(c1)I)Oc1cc(I)c(c(c1)I)O)N,""InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1"",XUIIKFGFIJCVMT-LBPRGKRZSA-N,";;
"Ligand,360,tolterodine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=360,Synthetic organic,,,,,443879,135651269,Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O,""InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1"",OOGJQPCLVADCPB-HXUWFJFHSA-N,";;
"Ligand,7161,diethylpropion,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7161,Synthetic organic,,,,,7029,178103736,CCN(C(C(=O)c1ccccc1)C)CC,""InChI=1S/C13H19NO/c1-4-14(5-2)11(3)13(15)12-9-7-6-8-10-12/h6-11H,4-5H2,1-3H3"",XXEPPPIWZFICOJ-UHFFFAOYSA-N,";;
"Ligand,6571,moexipril,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6571,Synthetic organic,,,,,91270,178103185,CCOC(=O)[C@@H](N[C@H](C(=O)N1Cc2cc(OC)c(cc2C[C@H]1C(=O)O)OC)C)CCc1ccccc1,""InChI=1S/C27H34N2O7/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32)/t17-,21-,22-/m0/s1"",UWWDHYUMIORJTA-HSQYWUDLSA-N,";;
"Ligand,6831,mycophenolate mofetil,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6831,Synthetic organic,,,,,5281078,178103437,COc1c(C/C=C(/CCC(=O)OCCN2CCOCC2)\C)c(O)c2c(c1C)COC2=O,""InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+"",RTGDFNSFWBGLEC-SYZQJQIISA-N,";;
"Ligand,7599,etretinate,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7599,Synthetic organic,,,,,5282375,223365934,CCOC(=O)/C=C(/C=C/C=C(/C=C/c1c(C)cc(c(c1C)C)OC)\C)\C,""InChI=1S/C23H30O3/c1-8-26-23(24)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(25-7)20(6)19(21)5/h9-15H,8H2,1-7H3/b11-9+,13-12+,16-10+,17-14+"",HQMNCQVAMBCHCO-DJRRULDNSA-N,";;
"Ligand,11705,fomepizole,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11705,Synthetic organic,,,,,3406,442878731,Cc1c[nH]nc1,""InChI=1S/C4H6N2/c1-4-2-5-6-3-4/h2-3H,1H3,(H,5,6)"",RIKMMFOAQPJVMX-UHFFFAOYSA-N,";;
"Ligand,11291,psilocin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11291,Natural product,,,,,4980,434321726,CN(CCc1c[nH]c2c1c(O)ccc2)C,""InChI=1S/C12H16N2O/c1-14(2)7-6-9-8-13-10-4-3-5-11(15)12(9)10/h3-5,8,13,15H,6-7H2,1-2H3"",SPCIYGNTAMCTRO-UHFFFAOYSA-N,";;
"Ligand,10958,hedamycin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10958,Natural product,,,,,98033,405560399,CN(C1CC(OC(C1O)C)c1cc(C2OC(C)C(C(C2)(C)N(C)C)O)c(c2c1C(=O)c1cc(C)c3c(c1C2=O)oc(cc3=O)C1(C)OC1C1OC1C)O)C,""InChI=1S/C41H50N2O11/c1-16-11-22-30(37-28(16)24(44)14-27(53-37)41(6)39(54-41)36-18(3)52-36)35(48)31-29(34(22)47)20(25-13-23(42(7)8)32(45)17(2)50-25)12-21(33(31)46)26-15-40(5,43(9)10)38(49)19(4)51-26/h11-12,14,17-19,23,25-26,32,36,38-39,45-46,49H,13,15H2,1-10H3"",RZOFHOWMWMTHDX-UHFFFAOYSA-N,";;
"Ligand,1766,BX 048,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1766,Synthetic organic,,,,,16741348,135650044,CCOC(=O)N1CCN(CC1)C(=O)C(NC(=O)c1cc(OC(C(=O)O)(C)C)c2c(n1)cc(cc2)C)CCC(=O)O,""InChI=1S/C27H34N4O9/c1-5-39-26(38)31-12-10-30(11-13-31)24(35)18(8-9-22(32)33)29-23(34)20-15-21(40-27(3,4)25(36)37)17-7-6-16(2)14-19(17)28-20/h6-7,14-15,18H,5,8-13H2,1-4H3,(H,29,34)(H,32,33)(H,36,37)"",MCBLPJPMVOVJCO-UHFFFAOYSA-N,";;
"Ligand,2924,fingolimod-phosphate,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2924,Synthetic organic,,,,,9908268,135650290,CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)O)(CO)N,""InChI=1S/C19H34NO5P/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-25-26(22,23)24/h9-12,21H,2-8,13-16,20H2,1H3,(H2,22,23,24)"",LRFKWQGGENFBFO-UHFFFAOYSA-N,";;
"Ligand,6705,o-hydroxyatorvastatin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6705,Synthetic organic,,,,,9808225,178103316,O[C@@H](C[C@H](CC(=O)O)O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccccc1O,""InChI=1S/C33H35FN2O6/c1-20(2)31-30(33(42)35-26-10-6-7-11-27(26)39)29(21-8-4-3-5-9-21)32(22-12-14-23(34)15-13-22)36(31)17-16-24(37)18-25(38)19-28(40)41/h3-15,20,24-25,37-39H,16-19H2,1-2H3,(H,35,42)(H,40,41)/t24-,25-/m1/s1"",CZBPKFICAYVHHM-JWQCQUIFSA-N,";;
"Ligand,9772,lenabasum,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9772,Synthetic organic,,,,,3083542,354702245,CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)C(=O)O)(C)C)(C)C,""InChI=1S/C25H36O4/c1-6-7-8-9-12-24(2,3)17-14-20(26)22-18-13-16(23(27)28)10-11-19(18)25(4,5)29-21(22)15-17/h10,14-15,18-19,26H,6-9,11-13H2,1-5H3,(H,27,28)/t18-,19-/m1/s1"",YCHYFHOSGQABSW-RTBURBONSA-N,";;
"Ligand,8360,iniparib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8360,Synthetic organic,,,,,9796068,252166572,[O-][N+](=O)c1cc(ccc1I)C(=O)N,""InChI=1S/C7H5IN2O3/c8-5-2-1-4(7(9)11)3-6(5)10(12)13/h1-3H,(H2,9,11)"",MDOJTZQKHMAPBK-UHFFFAOYSA-N,";;
"Ligand,3150,FR-49175,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3150,Natural product,,,,,194564,178100262,CS[C@]12CC3=CC=C[C@@H]([C@H]3N2C(=O)[C@](N(C1=O)C)(SC)CO)O,""InChI=1S/C15H20N2O4S2/c1-16-12(20)14(22-2)7-9-5-4-6-10(19)11(9)17(14)13(21)15(16,8-18)23-3/h4-6,10-11,18-19H,7-8H2,1-3H3/t10-,11-,14+,15+/m0/s1"",OVBAGMZLGLXSBN-UOVKNHIHSA-N,";;
"Ligand,2817,4-hydroxytamoxifen,4HT,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2817,Synthetic organic,,,,,5284643,135649800,CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccc(cc1)O,""InChI=1S/C26H29NO2/c1-4-25(20-10-14-23(28)15-11-20)26(21-8-6-5-7-9-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25-"",DODQJNMQWMSYGS-QPLCGJKRSA-N,";;
Ligand,8253,sacituzumab govitecan,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8253,Antibody,,,,,,249565933,,,,;;
"Ligand,9650,dagrocorat,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9650,Synthetic organic,,,,,24873449,340590280,O=C(c1ccc2c(c1)CC[C@H]1[C@]2(CC[C@](C1)(O)C(F)(F)F)Cc1ccccc1)Nc1cccnc1C,""InChI=1S/C29H29F3N2O2/c1-19-25(8-5-15-33-19)34-26(35)22-10-12-24-21(16-22)9-11-23-18-28(36,29(30,31)32)14-13-27(23,24)17-20-6-3-2-4-7-20/h2-8,10,12,15-16,23,36H,9,11,13-14,17-18H2,1H3,(H,34,35)/t23-,27+,28-/m1/s1"",QJJBNCHSWFGXML-KEKPKEOLSA-N,";;
"Ligand,7598,acitretin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7598,Synthetic organic,,,,,5284513,223365933,COc1cc(C)c(c(c1C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C,""InChI=1S/C21H26O3/c1-14(8-7-9-15(2)12-21(22)23)10-11-19-16(3)13-20(24-6)18(5)17(19)4/h7-13H,1-6H3,(H,22,23)/b9-7+,11-10+,14-8+,15-12+"",IHUNBGSDBOWDMA-AQFIFDHZSA-N,";;
"Ligand,7592,difenoxin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7592,Synthetic organic,,,,,34328,223365927,N#CC(c1ccccc1)(c1ccccc1)CCN1CCC(CC1)(C(=O)O)c1ccccc1,""InChI=1S/C28H28N2O2/c29-22-28(24-12-6-2-7-13-24,25-14-8-3-9-15-25)18-21-30-19-16-27(17-20-30,26(31)32)23-10-4-1-5-11-23/h1-15H,16-21H2,(H,31,32)"",UFIVBRCCIRTJTN-UHFFFAOYSA-N,";;
"Ligand,7495,apicidin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7495,Natural product,Antimalarial ligands,,,,6918328,187051797,CCC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCCN2C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1cn(c2c1cccc2)OC)[C@H](CC)C,""InChI=1S/C34H49N5O6/c1-5-22(3)30-34(44)38-19-13-12-18-29(38)33(43)35-26(16-9-7-8-14-24(40)6-2)31(41)36-27(32(42)37-30)20-23-21-39(45-4)28-17-11-10-15-25(23)28/h10-11,15,17,21-22,26-27,29-30H,5-9,12-14,16,18-20H2,1-4H3,(H,35,43)(H,36,41)(H,37,42)/t22-,26-,27-,29+,30-/m0/s1"",JWOGUUIOCYMBPV-GMFLJSBRSA-N,";;
"Ligand,9454,PQA-18,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9454,Synthetic organic,,,,,46910769,329968394,CC(=CCOc1cc(nc2c1cccc2OCC=C(C)C)C(=O)OCC=C(C)C)C,""InChI=1S/C25H31NO4/c1-17(2)10-13-28-22-9-7-8-20-23(29-14-11-18(3)4)16-21(26-24(20)22)25(27)30-15-12-19(5)6/h7-12,16H,13-15H2,1-6H3"",APPXFGJVXDYNBO-UHFFFAOYSA-N,";;
"Ligand,7091,norgestimate,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7091,Metabolite,,,,,6540478,178103669,O/N=C/1\CC[C@H]2C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@]2(C#C)OC(=O)C)CC,""InChI=1S/C23H31NO3/c1-4-22-12-10-19-18-9-7-17(24-26)14-16(18)6-8-20(19)21(22)11-13-23(22,5-2)27-15(3)25/h2,14,18-21,26H,4,6-13H2,1,3H3/b24-17+/t18-,19+,20+,21-,22-,23-/m0/s1"",KIQQMECNKUGGKA-NMYWJIRASA-N,";;
"Ligand,9263,GDC-0834,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9263,Synthetic organic,,,,,25234918,315661338,CN1CCN(C(=O)[C@H]1c1ccc(cc1)Nc1nc(cn(c1=O)C)c1cccc(c1C)NC(=O)c1cc2c(s1)CCCC2)C,""InChI=1S/C33H36N6O3S/c1-20-24(9-7-10-25(20)36-31(40)28-18-22-8-5-6-11-27(22)43-28)26-19-39(4)33(42)30(35-26)34-23-14-12-21(13-15-23)29-32(41)38(3)17-16-37(29)2/h7,9-10,12-15,18-19,29H,5-6,8,11,16-17H2,1-4H3,(H,34,35)(H,36,40)/t29-/m1/s1"",CDOOFZZILLRUQH-GDLZYMKVSA-N,";;
"Ligand,9225,lisofylline,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9225,Synthetic organic,,,,,501254,315661300,C[C@H](CCCCn1c(=O)c2n(C)cnc2n(c1=O)C)O,""InChI=1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8-9,18H,4-7H2,1-3H3/t9-/m1/s1"",NSMXQKNUPPXBRG-SECBINFHSA-N,";;
"Ligand,6952,tazarotene,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6952,Synthetic organic,,,,,5381,178103534,CCOC(=O)c1ccc(nc1)C#Cc1ccc2c(c1)C(C)(C)CCS2,""InChI=1S/C21H21NO2S/c1-4-24-20(23)16-7-9-17(22-14-16)8-5-15-6-10-19-18(13-15)21(2,3)11-12-25-19/h6-7,9-10,13-14H,4,11-12H2,1-3H3"",OGQICQVSFDPSEI-UHFFFAOYSA-N,";;
"Ligand,6921,calcifediol,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6921,Metabolite,,,,,5283731,178103503,O[C@H]1CCC(=C)/C(=C\C=C\2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](CCCC(O)(C)C)C)C)/C1,""InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1"",JWUBBDSIWDLEOM-DTOXIADCSA-N,";;
"Ligand,7402,phenacetin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7402,Synthetic organic,,,,,4754,178103974,CCOc1ccc(cc1)NC(=O)C,""InChI=1S/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12)"",CPJSUEIXXCENMM-UHFFFAOYSA-N,";;
"Ligand,7307,ticlopidine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7307,Synthetic organic,,,,,5472,178103880,Clc1ccccc1CN1CCc2c(C1)ccs2,""InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2"",PHWBOXQYWZNQIN-UHFFFAOYSA-N,";;
"Ligand,9001,BIA 10-2474,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9001,Synthetic organic,,,,,46831476,310264779,[O-][n+]1cccc(c1)c1ncn(c1)C(=O)N(C1CCCCC1)C,""InChI=1S/C16H20N4O2/c1-18(14-7-3-2-4-8-14)16(21)19-11-15(17-12-19)13-6-5-9-20(22)10-13/h5-6,9-12,14H,2-4,7-8H2,1H3"",DOWVMJFBDGWVML-UHFFFAOYSA-N,";;
"Ligand,6332,enalaprilat,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6332,Synthetic organic,,,,,5462501,178102950,OC(=O)[C@@H](N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C)CCc1ccccc1,""InChI=1S/C18H24N2O5/c1-12(16(21)20-11-5-8-15(20)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25)/t12-,14-,15-/m0/s1"",LZFZMUMEGBBDTC-QEJZJMRPSA-N,";;
"Ligand,8919,AR-67,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8919,Synthetic organic,,,,,6712744,310264700,CC[C@@]1(O)C(=O)OCc2c1cc1c3nc4ccc(cc4c(c3Cn1c2=O)[Si](C(C)(C)C)(C)C)O,""InChI=1S/C26H30N2O5Si/c1-7-26(32)18-11-20-21-16(12-28(20)23(30)17(18)13-33-24(26)31)22(34(5,6)25(2,3)4)15-10-14(29)8-9-19(15)27-21/h8-11,29,32H,7,12-13H2,1-6H3/t26-/m0/s1"",XUSKJHCMMWAAHV-SANMLTNESA-N,";;
"Ligand,8854,combretastatin A4,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8854,Synthetic organic,,,,,5351344,252827511,COc1cc(/C=C\c2ccc(c(c2)O)OC)cc(c1OC)OC,""InChI=1S/C18H20O5/c1-20-15-8-7-12(9-14(15)19)5-6-13-10-16(21-2)18(23-4)17(11-13)22-3/h5-11,19H,1-4H3/b6-5-"",HVXBOLULGPECHP-WAYWQWQTSA-N,";;
"Ligand,7240,midodrine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7240,Synthetic organic,,,,,4195,178103814,COc1ccc(cc1C(CN=C(CN)O)O)OC,""InChI=1S/C12H18N2O4/c1-17-8-3-4-11(18-2)9(5-8)10(15)7-14-12(16)6-13/h3-5,10,15H,6-7,13H2,1-2H3,(H,14,16)"",PTKSEFOSCHHMPD-UHFFFAOYSA-N,";;
"Ligand,7199,hydroxyzine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7199,Synthetic organic,,,,,3658,178103774,OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1,""InChI=1S/C21H27ClN2O2/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-9,21,25H,10-17H2"",ZQDWXGKKHFNSQK-UHFFFAOYSA-N,";;
"Ligand,7157,desloratadine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7157,Synthetic organic,,,,,124087,178103732,Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1,""InChI=1S/C19H19ClN2/c20-16-5-6-17-15(12-16)4-3-14-2-1-9-22-19(14)18(17)13-7-10-21-11-8-13/h1-2,5-6,9,12,21H,3-4,7-8,10-11H2"",JAUOIFJMECXRGI-UHFFFAOYSA-N,";;
"Ligand,7154,cyclophosphamide,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7154,Synthetic organic,,,,,2907,178103729,ClCCN(P1(=O)NCCCO1)CCCl,""InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)"",CMSMOCZEIVJLDB-UHFFFAOYSA-N,";;
"Ligand,7158,desvenlafaxine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7158,Synthetic organic,,,,,125017,178103733,CN(CC(C1(O)CCCCC1)c1ccc(cc1)O)C,""InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3"",KYYIDSXMWOZKMP-UHFFFAOYSA-N,";;
"Ligand,8707,deutetrabenazine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8707,Synthetic organic,,,,,73437646,252827365,CC(C[C@@H]1CN2CCc3c([C@H]2CC1=O)cc(c(c3)OC([2H])([2H])[2H])OC([2H])([2H])[2H])C,""InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16-/m1/s1/i3D3,4D3"",MKJIEFSOBYUXJB-VFJJUKLQSA-N,";;
"Ligand,7537,norzotepine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7537,Synthetic organic,,,,,10041551,187051838,CNCCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2,""InChI=1S/C17H16ClNOS/c1-19-8-9-20-15-10-12-4-2-3-5-16(12)21-17-7-6-13(18)11-14(15)17/h2-7,10-11,19H,8-9H2,1H3"",OVVBIIBBRZVPAL-UHFFFAOYSA-N,";;
"Ligand,6467,pralnacasan,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6467,Synthetic organic,,,,,153270,178103081,CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN2N1C(=O)[C@H](CCC2=O)NC(=O)c1nccc2c1cccc2,""InChI=1S/C26H29N5O7/c1-2-37-26-18(14-21(33)38-26)29-23(34)19-8-5-13-30-20(32)10-9-17(25(36)31(19)30)28-24(35)22-16-7-4-3-6-15(16)11-12-27-22/h3-4,6-7,11-12,17-19,26H,2,5,8-10,13-14H2,1H3,(H,28,35)(H,29,34)/t17-,18-,19-,26+/m0/s1"",CXAGHAZMQSCAKJ-WAHHBDPQSA-N,";;
"Ligand,6382,melagatran,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6382,Synthetic organic,,,,,183797,178103000,OC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(cc1)C(=N)N)C1CCCCC1,""InChI=1S/C22H31N5O4/c23-20(24)16-8-6-14(7-9-16)12-26-21(30)17-10-11-27(17)22(31)19(25-13-18(28)29)15-4-2-1-3-5-15/h6-9,15,17,19,25H,1-5,10-13H2,(H3,23,24)(H,26,30)(H,28,29)/t17-,19+/m0/s1"",DKWNMCUOEDMMIN-PKOBYXMFSA-N,";;
"Ligand,6375,benazeprilat,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6375,Synthetic organic,,,,,5463984,178102993,OC(=O)CN1C(=O)[C@H](CCc2c1cccc2)N[C@H](C(=O)O)CCc1ccccc1,""InChI=1S/C22H24N2O5/c25-20(26)14-24-19-9-5-4-8-16(19)11-13-17(21(24)27)23-18(22(28)29)12-10-15-6-2-1-3-7-15/h1-9,17-18,23H,10-14H2,(H,25,26)(H,28,29)/t17-,18-/m0/s1"",MADRIHWFJGRSBP-ROUUACIJSA-N,";;
"Ligand,8388,chaetocin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8388,Natural product,,,,,161591,252166599,OCC12SSC3(N(C1=O)C1Nc4c(C1(C3)C13CC56N(C3Nc3c1cccc3)C(=O)C(SS5)(N(C6=O)C)CO)cccc4)C(=O)N2C,""InChI=1S/C30H28N6O6S4/c1-33-21(39)27-11-25(15-7-3-5-9-17(15)31-19(25)35(27)23(41)29(33,13-37)45-43-27)26-12-28-22(40)34(2)30(14-38,46-44-28)24(42)36(28)20(26)32-18-10-6-4-8-16(18)26/h3-10,19-20,31-32,37-38H,11-14H2,1-2H3"",PZPPOCZWRGNKIR-UHFFFAOYSA-N,";;
"Ligand,5816,taprenepag,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5816,Synthetic organic,,,,,18376177,178102441,OC(=O)COc1cccc(c1)CN(S(=O)(=O)c1cccnc1)Cc1ccc(cc1)n1cccn1,""InChI=1S/C24H22N4O5S/c29-24(30)18-33-22-5-1-4-20(14-22)17-27(34(31,32)23-6-2-11-25-15-23)16-19-7-9-21(10-8-19)28-13-3-12-26-28/h1-15H,16-18H2,(H,29,30)"",MFFBXYNKZHTCEY-UHFFFAOYSA-N,";;
Ligand,5217,L-&alpha;"-methyldopa,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5217,Synthetic organic,,,,,38853,178101902,OC(=O)[C@](Cc1ccc(c(c1)O)O)(N)C,""InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1"",CJCSPKMFHVPWAR-JTQLQIEISA-N,";
Ligand,8252,labetuzumab govitecan,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8252,Antibody,,,,,,249565932,,,,;;
"Ligand,8142,balanol,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8142,Natural product,,,,,5287736,249565822,Oc1ccc(cc1)C(=O)N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(c(c1)O)C(=O)c1c(O)cccc1C(=O)O,""InChI=1S/C28H26N2O10/c31-16-8-6-14(7-9-16)26(36)30-18-13-29-10-2-5-22(18)40-28(39)15-11-20(33)24(21(34)12-15)25(35)23-17(27(37)38)3-1-4-19(23)32/h1,3-4,6-9,11-12,18,22,29,31-34H,2,5,10,13H2,(H,30,36)(H,37,38)/t18-,22-/m1/s1"",XYUFCXJZFZPEJD-XMSQKQJNSA-N,";;
"Ligand,7961,ME-344,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7961,Synthetic organic,,,,,68026984,249565644,Oc1ccc(cc1)[C@@H]1COc2c([C@@H]1c1ccc(cc1)O)ccc(c2C)O,""InChI=1S/C22H20O4/c1-13-20(25)11-10-18-21(15-4-8-17(24)9-5-15)19(12-26-22(13)18)14-2-6-16(23)7-3-14/h2-11,19,21,23-25H,12H2,1H3/t19-,21-/m0/s1"",QVCAATSEPLQVBX-FPOVZHCZSA-N,";;
"Ligand,4789,5-fluorouracil,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4789,Synthetic organic,,,,,3385,178101491,Fc1c[nH]c(=O)[nH]c1=O,""InChI=1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)"",GHASVSINZRGABV-UHFFFAOYSA-N,";;
Ligand,4711,&gamma;"-hydroxybutyric acid,GHB,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4711,Metabolite,,,,,10413,178101422,OCCCC(=O)O,""InChI=1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7)"",SJZRECIVHVDYJC-UHFFFAOYSA-N,";
"Ligand,4233,ketamine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4233,Synthetic organic,,,,,3821,178101050,CNC1(CCCCC1=O)c1ccccc1Cl,""InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3"",YQEZLKZALYSWHR-UHFFFAOYSA-N,";;
"Ligand,7747,inecalcitol,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7747,Natural product,,,,,6915835,223366080,O[C@H]1C[C@H](O)CC(=C/C=C/2\CCC[C@]3([C@@H]2CC[C@@H]3[C@@H](CC#CC(O)(C)C)C)C)C1,""InChI=1S/C26H40O3/c1-18(7-5-13-25(2,3)29)23-11-12-24-20(8-6-14-26(23,24)4)10-9-19-15-21(27)17-22(28)16-19/h9-10,18,21-24,27-29H,6-8,11-12,14-17H2,1-4H3/b20-10+/t18-,21-,22-,23-,24-,26-/m1/s1"",HHGRMHMXKPQNGF-WNSNRMDMSA-N,";;
"Ligand,7565,amfenac,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7565,Synthetic organic,Non-steroidal anti-inflammatory ligands,,,,2136,223365901,OC(=O)Cc1cccc(c1N)C(=O)c1ccccc1,""InChI=1S/C15H13NO3/c16-14-11(9-13(17)18)7-4-8-12(14)15(19)10-5-2-1-3-6-10/h1-8H,9,16H2,(H,17,18)"",SOYCMDCMZDHQFP-UHFFFAOYSA-N,";;
"Ligand,60,zolmitriptan,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=60,Synthetic organic,,,,,60857,135651366,CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C,""InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1"",ULSDMUVEXKOYBU-ZDUSSCGKSA-N,";;
"Ligand,2949,atorvastatin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2949,Synthetic organic,,,,,60823,135649972,O[C@@H](C[C@H](CC(=O)O)O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccccc1,""InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1"",XUKUURHRXDUEBC-KAYWLYCHSA-N,";;
"Ligand,5852,MRE-269,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5852,Synthetic organic,,,,,9931891,178102476,OC(=O)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C,""InChI=1S/C25H29N3O3/c1-19(2)28(15-9-10-16-31-18-23(29)30)22-17-26-24(20-11-5-3-6-12-20)25(27-22)21-13-7-4-8-14-21/h3-8,11-14,17,19H,9-10,15-16,18H2,1-2H3,(H,29,30)"",OJQMKCBWYCWFPU-UHFFFAOYSA-N,";;
"Ligand,1936,misoprostol (methyl ester),,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1936,Synthetic organic,,,,,5282381,135650611,CCCCC(C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC)(O)C,""InChI=1S/C22H38O5/c1-4-5-14-22(2,26)15-10-12-18-17(19(23)16-20(18)24)11-8-6-7-9-13-21(25)27-3/h10,12,17-18,20,24,26H,4-9,11,13-16H2,1-3H3/b12-10+/t17-,18-,20-,22?/m1/s1"",OJLOPKGSLYJEMD-URPKTTJQSA-N,";;
"Ligand,1016,tamoxifen,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1016,Synthetic organic,,,,,2733526,135651233,CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1,""InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-"",NKANXQFJJICGDU-QPLCGJKRSA-N,";;
"Ligand,38,clozapine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38,Synthetic organic,,,,,135398737,135650115,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2,""InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3"",QZUDBNBUXVUHMW-UHFFFAOYSA-N,";;
"Ligand,203,fluoxetine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=203,Synthetic organic,,,,,3386,135650270,CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F,""InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3"",RTHCYVBBDHJXIQ-UHFFFAOYSA-N,";;
"Ligand,10247,cladosporin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10247,Natural product,Antimalarial ligands,,,,13990016,381744929,C[C@H]1CCC[C@@H](O1)C[C@@H]1OC(=O)c2c(C1)cc(cc2O)O,""InChI=1S/C16H20O5/c1-9-3-2-4-12(20-9)8-13-6-10-5-11(17)7-14(18)15(10)16(19)21-13/h5,7,9,12-13,17-18H,2-4,6,8H2,1H3/t9-,12+,13+/m0/s1"",WOMKDMUZNBFXKG-ZWKOPEQDSA-N,";;
"Ligand,2608,terfenadine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2608,Synthetic organic,,,,,5405,135651245,OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O,""InChI=1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3"",GUGOEEXESWIERI-UHFFFAOYSA-N,";;
"Ligand,10978,Macquarimicin A,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10978,Synthetic organic,,,,,10019526,405560419,O[C@H]1C[C@@H]2CC(=O)/C(=C\[C@H]3[C@@H](C1)C=C[C@H]1[C@@H]3C[C@H](C1=O)C)/C(=O)O2,""InChI=1S/C19H22O5/c1-9-4-15-13(18(9)22)3-2-10-5-11(20)6-12-7-17(21)16(8-14(10)15)19(23)24-12/h2-3,8-15,20H,4-7H2,1H3/b16-8+/t9-,10-,11-,12-,13+,14+,15+/m1/s1"",BYUKEFZLYIFNCB-MDRYBKLPSA-N,";;
Ligand,8251,labetuzumab,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8251,Antibody,,,,,,249565931,,,,;;
"Ligand,8321,bempedoic acid,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8321,Synthetic organic,,,,,10472693,252166533,OC(CCCCCC(C(=O)O)(C)C)CCCCCC(C(=O)O)(C)C,""InChI=1S/C19H36O5/c1-18(2,16(21)22)13-9-5-7-11-15(20)12-8-6-10-14-19(3,4)17(23)24/h15,20H,5-14H2,1-4H3,(H,21,22)(H,23,24)"",HYHMLYSLQUKXKP-UHFFFAOYSA-N,";;
"Ligand,7545,<i>N</i>-desalkylquetiapine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7545,Synthetic organic,,,,,11369918,187051846,N1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2,""InChI=1S/C17H17N3S/c1-3-7-15-13(5-1)17(20-11-9-18-10-12-20)19-14-6-2-4-8-16(14)21-15/h1-8,18H,9-12H2"",JLOAJISUHPIQOX-UHFFFAOYSA-N,";;
"Ligand,7150,clopidogrel,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7150,Synthetic organic,,,,,60606,178103725,COC(=O)[C@H](c1ccccc1Cl)N1CCc2c(C1)ccs2,""InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1"",GKTWGGQPFAXNFI-HNNXBMFYSA-N,";;
"Ligand,1771,R-138727,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1771,Synthetic organic,,,,,10405534,135650878,OC(=O)/C=C\1/CN(CCC1S)C(c1ccccc1F)C(=O)C1CC1,""InChI=1S/C18H20FNO3S/c19-14-4-2-1-3-13(14)17(18(23)11-5-6-11)20-8-7-15(24)12(10-20)9-16(21)22/h1-4,9,11,15,17,24H,5-8,10H2,(H,21,22)/b12-9-"",ZWUQVNSJSJHFPS-XFXZXTDPSA-N,";;
"Ligand,6925,SN-38,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6925,Synthetic organic,,,,,104842,178103507,CC[C@@]1(O)C(=O)OCc2c1cc1c3nc4ccc(cc4c(c3Cn1c2=O)CC)O,""InChI=1S/C22H20N2O5/c1-3-12-13-7-11(25)5-6-17(13)23-19-14(12)9-24-18(19)8-16-15(20(24)26)10-29-21(27)22(16,28)4-2/h5-8,25,28H,3-4,9-10H2,1-2H3/t22-/m0/s1"",FJHBVJOVLFPMQE-QFIPXVFZSA-N,";;
"Ligand,333,<i>N</i>-desmethylclozapine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=333,Synthetic organic,,,,,2820,135650395,Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1,""InChI=1S/C17H17ClN4/c18-12-5-6-15-16(11-12)21-17(22-9-7-19-8-10-22)13-3-1-2-4-14(13)20-15/h1-6,11,19,21H,7-10H2"",HESZUPIXRNZIOI-UHFFFAOYSA-N,";;
"Ligand,7090,nelarabine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7090,Synthetic organic,,,,,3011155,178103668,OC[C@H]1O[C@H]([C@H]([C@@H]1O)O)n1cnc2c1[nH]c(=N)nc2OC,""InChI=1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7+,10-/m1/s1"",IXOXBSCIXZEQEQ-UHTZMRCNSA-N,";;
"Ligand,6378,imidaprilat,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6378,Synthetic organic,,,,,5464344,178102996,C[C@@H](C(=O)N1C(=O)N(C[C@H]1C(=O)O)C)N[C@H](C(=O)O)CCc1ccccc1,""InChI=1S/C18H23N3O6/c1-11(15(22)21-14(17(25)26)10-20(2)18(21)27)19-13(16(23)24)9-8-12-6-4-3-5-7-12/h3-7,11,13-14,19H,8-10H2,1-2H3,(H,23,24)(H,25,26)/t11-,13-,14-/m0/s1"",VFAVNRVDTAPBNR-UBHSHLNASA-N,";;
"Ligand,7590,etonogestrel,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7590,Synthetic organic,,,,,6917715,223365925,C#C[C@]1(O)CC[C@@H]2[C@]1(CC)CC(=C)[C@H]1[C@H]2CCC2=CC(=O)CC[C@H]12,""InChI=1S/C22H28O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,12,17-20,24H,3-4,6-11,13H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1"",GCKFUYQCUCGESZ-BPIQYHPVSA-N,";;
"Ligand,10754,afabicin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10754,Synthetic organic,,,,,72696796,405560195,O=C(N(Cc1oc2c(c1C)cccc2)C)/C=C/c1cnc2c(c1)CCC(=O)N2COP(=O)(O)O,""InChI=1S/C23H24N3O7P/c1-15-18-5-3-4-6-19(18)33-20(15)13-25(2)21(27)9-7-16-11-17-8-10-22(28)26(23(17)24-12-16)14-32-34(29,30)31/h3-7,9,11-12H,8,10,13-14H2,1-2H3,(H2,29,30,31)/b9-7+"",HFYMDQMXVPJNTH-VQHVLOKHSA-N,";;
"Ligand,10904,daptomycin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10904,Synthetic organic,,,,,16134395,405560345,NCCC[C@@H]1NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc2c[nH]c3c2cccc3)NC(=O)CCCCCCCCC)CC(=O)N)CC(=O)O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)O)C)CC(=O)O)CO)[C@@H](CC(=O)O)C)CC(=O)c1ccccc1N,""InChI=1S/C72H101N17O26/c1-5-6-7-8-9-10-11-22-53(93)81-44(25-38-31-76-42-20-15-13-17-39(38)42)66(108)84-45(27-52(75)92)67(109)86-48(30-59(102)103)68(110)89-61-37(4)115-72(114)49(26-51(91)40-18-12-14-19-41(40)74)87-71(113)60(35(2)24-56(96)97)88-69(111)50(34-90)82-55(95)32-77-63(105)46(28-57(98)99)83-62(104)36(3)79-65(107)47(29-58(100)101)85-64(106)43(21-16-23-73)80-54(94)33-78-70(61)112/h12-15,17-20,31,35-37,43-50,60-61,76,90H,5-11,16,21-30,32-34,73-74H2,1-4H3,(H2,75,92)(H,77,105)(H,78,112)(H,79,107)(H,80,94)(H,81,93)(H,82,95)(H,83,104)(H,84,108)(H,85,106)(H,86,109)(H,87,113)(H,88,111)(H,89,110)(H,96,97)(H,98,99)(H,100,101)(H,102,103)/t35-,36-,37-,43+,44+,45+,46+,47+,48+,49+,50-,60+,61+/m1/s1"",DOAKLVKFURWEDJ-RWDRXURGSA-N,";;
"Ligand,7389,acelarin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7389,Synthetic organic,,,,,73755261,178103961,O=C([C@@H](NP(=O)(Oc1ccccc1)OC[C@H]1O[C@H](C([C@H]1O)(F)F)n1ccc(nc1=O)N)C)OCc1ccccc1,""InChI=1S/C25H27F2N4O8P/c1-16(22(33)36-14-17-8-4-2-5-9-17)30-40(35,39-18-10-6-3-7-11-18)37-15-19-21(32)25(26,27)23(38-19)31-13-12-20(28)29-24(31)34/h2-13,16,19,21,23,32H,14-15H2,1H3,(H,30,35)(H2,28,29,34)/t16-,19+,21-,23+,40?/m0/s1"",NHTKGYOMICWFQZ-BSMFTPRPSA-N,";;
"Ligand,9603,BIA 10-2639,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9603,Synthetic organic,,,,,66554294,340590233,CN(C(=O)n1cnc(c1)c1cccnc1)C1CCCCC1,""InChI=1S/C16H20N4O/c1-19(14-7-3-2-4-8-14)16(21)20-11-15(18-12-20)13-6-5-9-17-10-13/h5-6,9-12,14H,2-4,7-8H2,1H3"",DWCWWJONKWHPDD-UHFFFAOYSA-N,";;
"Ligand,7473,fesoterodine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7473,Synthetic organic,,,,,6918558,187051776,OCc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)OC(=O)C(C)C,""InChI=1S/C26H37NO3/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3/t23-/m1/s1"",DCCSDBARQIPTGU-HSZRJFAPSA-N,";;
"Ligand,12058,2-Methoxyestradiol,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12058,Metabolite,,,,,66414,472319180,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCc1cc(c(cc31)OC)O,""InChI=1S/C19H26O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,18,20-21H,3-8H2,1-2H3/t12-,13+,15-,18-,19-/m0/s1"",CQOQDQWUFQDJMK-SSTWWWIQSA-N,";;
"Ligand,11973,HR1405-01,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11973,Synthetic organic,,,,,10037656,464244114,O[C@@H]1[C@H](CCC1)Cc1ccc(cc1)[C@@H](C(=O)O)C,""InChI=1S/C15H20O3/c1-10(15(17)18)12-7-5-11(6-8-12)9-13-3-2-4-14(13)16/h5-8,10,13-14,16H,2-4,9H2,1H3,(H,17,18)/t10-,13+,14-/m0/s1"",SHAHPWSYJFYMRX-GDLCADMTSA-N,";;
"Ligand,11900,5-hydroxyindoleacetic acid,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11900,Synthetic organic,,,,,,461663455,c1cc2c(cc1O)c(c[nH]2)CC(=O)O,""InChI=1S/C10H9NO3/c12-7-1-2-9-8(4-7)6(5-11-9)3-10(13)14/h1-2,4-5,11-12H,3H2,(H,13,14)"",DUUGKQCEGZLZNO-UHFFFAOYSA-N,";;
"Ligand,11899,remdesivir triphosphate,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11899,Synthetic organic,,,,,56832906,461663454,c1c2c(ncnn2c(c1)[C@]1([C@@H]([C@@H]([C@H](O1)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)C#N)N,""InChI=1S/C12H16N5O13P3/c13-4-12(8-2-1-6-11(14)15-5-16-17(6)8)10(19)9(18)7(28-12)3-27-32(23,24)30-33(25,26)29-31(20,21)22/h1-2,5,7,9-10,18-19H,3H2,(H,23,24)(H,25,26)(H2,14,15,16)(H2,20,21,22)/t7-,9-,10-,12+/m1/s1"",DFVPCNAMNAPBCX-LTGWCKQJSA-N,";;
"Ligand,5278,thiorphan,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5278,Synthetic organic,,,,,4369380,178101961,SC[C@H](C(=O)NCC(=O)O)Cc1ccccc1,""InChI=1S/C12H15NO3S/c14-11(15)7-13-12(16)10(8-17)6-9-4-2-1-3-5-9/h1-5,10,17H,6-8H2,(H,13,16)(H,14,15)/t10-/m1/s1"",LJJKNPQAGWVLDQ-SNVBAGLBSA-N,";;
"Ligand,11445,GS-441524,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11445,Synthetic organic,,,,,44468216,440816814,OC[C@H]1O[C@@]([C@@H]([C@@H]1O)O)(C#N)c1ccc2n1ncnc2N,""InChI=1S/C12H13N5O4/c13-4-12(10(20)9(19)7(3-18)21-12)8-2-1-6-11(14)15-5-16-17(6)8/h1-2,5,7,9-10,18-20H,3H2,(H2,14,15,16)/t7-,9-,10-,12+/m1/s1"",BRDWIEOJOWJCLU-LTGWCKQJSA-N,";;
"Ligand,1961,latanoprost (isopropyl ester),,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1961,Synthetic organic,,,,,5311221,135650509,O[C@@H](CCc1ccccc1)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)OC(C)C)O,""InChI=1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1"",GGXICVAJURFBLW-CEYXHVGTSA-N,";;
"Ligand,11493,BMS-986166,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11493,Synthetic organic,,,,,118877516,440816861,OC[C@@]1(N)CC[C@@H](C1)c1ccc2c(c1)CC[C@H](C2)CCc1ccccc1OC,""InChI=1S/C25H33NO2/c1-28-24-5-3-2-4-19(24)8-6-18-7-9-21-15-22(11-10-20(21)14-18)23-12-13-25(26,16-23)17-27/h2-5,10-11,15,18,23,27H,6-9,12-14,16-17,26H2,1H3/t18-,23+,25-/m1/s1"",QCMHGCDOZLWPOT-FMNCTDSISA-N,";;
"Ligand,11250,PF-00835231,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11250,Synthetic organic,,,,,11561899,434122310,OCC(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1[nH]c2c(c1)c(OC)ccc2)CC(C)C)C[C@@H]1CCNC1=O,""InChI=1S/C24H32N4O6/c1-13(2)9-18(23(32)27-17(20(30)12-29)10-14-7-8-25-22(14)31)28-24(33)19-11-15-16(26-19)5-4-6-21(15)34-3/h4-6,11,13-14,17-18,26,29H,7-10,12H2,1-3H3,(H,25,31)(H,27,32)(H,28,33)/t14-,17-,18-/m0/s1"",QDIMHKWNHMVDJB-WBAXXEDZSA-N,";;
"Ligand,11427,oseltamivir,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11427,Synthetic organic,,,,,65028,440816796,CCOC(=O)C1=C[C@H]([C@@H]([C@H](C1)N)NC(=O)C)OC(CC)CC,""InChI=1S/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1"",VSZGPKBBMSAYNT-RRFJBIMHSA-N,";;
"Ligand,208,norfluoxetine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=208,Synthetic organic,,,,,4541,135650734,NCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F,""InChI=1S/C16H16F3NO/c17-16(18,19)13-6-8-14(9-7-13)21-15(10-11-20)12-4-2-1-3-5-12/h1-9,15H,10-11,20H2"",WIQRCHMSJFFONW-UHFFFAOYSA-N,";;
"Ligand,6829,methocarbamol,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6829,Synthetic organic,,,,,4107,178103435,COc1ccccc1OCC(COC(=O)N)O,""InChI=1S/C11H15NO5/c1-15-9-4-2-3-5-10(9)16-6-8(13)7-17-11(12)14/h2-5,8,13H,6-7H2,1H3,(H2,12,14)"",GNXFOGHNGIVQEH-UHFFFAOYSA-N,";;
"Ligand,10755,DEBIO 1452,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10755,Synthetic organic,,,,,10407120,405560196,O=C1CCc2c(N1)ncc(c2)/C=C/C(=O)N(Cc1oc2c(c1C)cccc2)C,""InChI=1S/C22H21N3O3/c1-14-17-5-3-4-6-18(17)28-19(14)13-25(2)21(27)10-7-15-11-16-8-9-20(26)24-22(16)23-12-15/h3-7,10-12H,8-9,13H2,1-2H3,(H,23,24,26)/b10-7+"",QXTWSUQCXCWEHF-JXMROGBWSA-N,";;
"Ligand,10715,remdesivir,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10715,Synthetic organic,,,,,121304016,404859162,CCC(COC(=O)[C@@H](N[P@@](=O)(Oc1ccccc1)OC[C@H]1O[C@@]([C@@H]([C@@H]1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,""InChI=1S/C27H35N6O8P/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)/t17-,21+,23+,24+,27-,42-/m0/s1"",RWWYLEGWBNMMLJ-YSOARWBDSA-N,";;
"Ligand,10663,vorasidenib,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10663,Synthetic organic,,,,,117817422,404859110,Clc1cccc(n1)c1nc(nc(n1)N[C@@H](C(F)(F)F)C)N[C@@H](C(F)(F)F)C,""InChI=1S/C14H13ClF6N6/c1-6(13(16,17)18)22-11-25-10(8-4-3-5-9(15)24-8)26-12(27-11)23-7(2)14(19,20)21/h3-7H,1-2H3,(H2,22,23,25,26,27)/t6-,7-/m1/s1"",QCZAWDGAVJMPTA-RNFRBKRXSA-N,";;
"Ligand,10511,carotegrast,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10511,Synthetic organic,,,,,10120218,387065593,CN(c1ccc2c(c1)c(=O)n(c(=O)n2C)c1ccc(cc1)C[C@@H](C(=O)O)NC(=O)c1c(Cl)cccc1Cl)C,""InChI=1S/C27H24Cl2N4O5/c1-31(2)17-11-12-22-18(14-17)25(35)33(27(38)32(22)3)16-9-7-15(8-10-16)13-21(26(36)37)30-24(34)23-19(28)5-4-6-20(23)29/h4-12,14,21H,13H2,1-3H3,(H,30,34)(H,36,37)/t21-/m0/s1"",YQKBOUPIOWUMTE-NRFANRHFSA-N,";;
"Ligand,10419,RIPK2 inhibitor 5,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10419,Synthetic organic,,,,,71258526,385612179,OCCOc1cc2ncnc(c2cc1S(=O)(=O)C(C)(C)C)Nc1ccc2c(c1)ncs2,""InChI=1S/C21H22N4O4S2/c1-21(2,3)31(27,28)19-9-14-15(10-17(19)29-7-6-26)22-11-23-20(14)25-13-4-5-18-16(8-13)24-12-30-18/h4-5,8-12,26H,6-7H2,1-3H3,(H,22,23,25)"",UHDOJINBFLDQJM-UHFFFAOYSA-N,";;
"Ligand,6432,camostat,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6432,Synthetic organic,,,,,2536,178103048,CN(C(=O)COC(=O)Cc1ccc(cc1)OC(=O)c1ccc(cc1)N=C(N)N)C,""InChI=1S/C20H22N4O5/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22/h3-10H,11-12H2,1-2H3,(H4,21,22,23)"",XASIMHXSUQUHLV-UHFFFAOYSA-N,";;
Ligand,10359,ulinastatin {Sp: Human},,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10359,Peptide,,,Human:AMBP,Human:453,,387271625,,,,;;
"Ligand,5786,monomethyl fumarate,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5786,Synthetic organic,,,,,5369209,178102411,COC(=O)/C=C/C(=O)O,""InChI=1S/C5H6O4/c1-9-5(8)3-2-4(6)7/h2-3H,1H3,(H,6,7)/b3-2+"",NKHAVTQWNUWKEO-NSCUHMNNSA-N,";;
"Ligand,10204,norendoxifen,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10204,Synthetic organic,,,,,68037237,381118914,NCCOc1ccc(cc1)/C(=C(\c1ccccc1)/CC)/c1ccc(cc1)O,""InChI=1S/C24H25NO2/c1-2-23(18-6-4-3-5-7-18)24(19-8-12-21(26)13-9-19)20-10-14-22(15-11-20)27-17-16-25/h3-15,26H,2,16-17,25H2,1H3/b24-23-"",YCQBLTPGQSYLHD-VHXPQNKSSA-N,";;
"Ligand,10203,endoxifen,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10203,Synthetic organic,,,,,10090750,381118913,CNCCOc1ccc(cc1)/C(=C(\c1ccccc1)/CC)/c1ccc(cc1)O,""InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3/b25-24-"",MHJBZVSGOZTKRH-IZHYLOQSSA-N,";;
"Ligand,4819,fexofenadine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4819,Synthetic organic,,,,,3348,178101521,OC(=O)C(c1ccc(cc1)C(CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O)O)(C)C,""InChI=1S/C32H39NO4/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36)"",RWTNPBWLLIMQHL-UHFFFAOYSA-N,";;
"Ligand,10130,SPRi3,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10130,Synthetic organic,,,,,52911386,381118840,COCC(=O)NCCc1c(C)[nH]c2c1cc(O)cc2,""InChI=1S/C14H18N2O3/c1-9-11(5-6-15-14(18)8-19-2)12-7-10(17)3-4-13(12)16-9/h3-4,7,16-17H,5-6,8H2,1-2H3,(H,15,18)"",YBXBWBBVLXZQBJ-UHFFFAOYSA-N,";;
"Ligand,10125,PFKFB3 kinase Inhibitor 69,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10125,Synthetic organic,,,,,122690758,381118835,Cc1csc2c1cc(cc2)c1cc(Nc2cnccc2S(=O)(=O)C)cc2c1nccn2,""InChI=1S/C23H18N4O2S2/c1-14-13-30-21-4-3-15(9-17(14)21)18-10-16(11-19-23(18)26-8-7-25-19)27-20-12-24-6-5-22(20)31(2,28)29/h3-13,27H,1-2H3"",CYJRNFFLTBEQSQ-UHFFFAOYSA-N,";;
"Ligand,10047,indole-3-carbinol,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10047,Synthetic organic,,,,,3712,375973235,OCc1c[nH]c2c1cccc2,""InChI=1S/C9H9NO/c11-6-7-5-10-9-4-2-1-3-8(7)9/h1-5,10-11H,6H2"",IVYPNXXAYMYVSP-UHFFFAOYSA-N,";;
"Ligand,10046,""indolo[3,2-b]carbazole"",,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10046,Synthetic organic,,,,,114764,375973234,c1ccc2c(c1)c1cc3=Nc4c(c3cc1=N2)cccc4,InChI=1S/C18H10N2/c1-3-7-15-11(5-1)13-9-18-14(10-17(13)19-15)12-6-2-4-8-16(12)20-18/h1-10H,HLVSZSQYBQCBQG-UHFFFAOYSA-N,";;
"Ligand,9958,artemotil,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9958,Natural product,Antimalarial ligands,,,,3000469,374883845,CCO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@@H]4[C@]2([C@H]([C@H]1C)CC[C@H]4C)OO3,""InChI=1S/C17H28O5/c1-5-18-14-11(3)13-7-6-10(2)12-8-9-16(4)20-15(19-14)17(12,13)22-21-16/h10-15H,5-9H2,1-4H3/t10-,11-,12+,13+,14+,15-,16-,17-/m1/s1"",NLYNIRQVMRLPIQ-XQLAAWPRSA-N,";;
"Ligand,9957,artenimol,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9957,Natural product,Antimalarial ligands,,,,3000518,374883844,O[C@H]1O[C@@H]2O[C@@]3(C)CC[C@@H]4[C@]2([C@H]([C@H]1C)CC[C@H]4C)OO3,""InChI=1S/C15H24O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-13,16H,4-7H2,1-3H3/t8-,9-,10+,11+,12+,13-,14-,15-/m1/s1"",BJDCWCLMFKKGEE-ISOSDAIHSA-N,";;
"Ligand,9956,artesunate,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9956,Synthetic organic,Antimalarial ligands,,,,6917864,374883843,OC(=O)CCC(=O)O[C@@H]1O[C@@H]2O[C@@]3(C)CC[C@@H]4[C@]2([C@H]([C@H]1C)CC[C@H]4C)OO3,""InChI=1S/C19H28O8/c1-10-4-5-13-11(2)16(23-15(22)7-6-14(20)21)24-17-19(13)12(10)8-9-18(3,25-17)26-27-19/h10-13,16-17H,4-9H2,1-3H3,(H,20,21)/t10-,11-,12+,13+,16-,17-,18-,19-/m1/s1"",FIHJKUPKCHIPAT-AHIGJZGOSA-N,";;
"Ligand,9954,artemisinin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9954,Natural product,Antimalarial ligands,,,,68827,374883841,O=C1O[C@@H]2O[C@@]3(C)CC[C@@H]4[C@]2([C@H]([C@H]1C)CC[C@H]4C)OO3,""InChI=1S/C15H22O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-11,13H,4-7H2,1-3H3/t8-,9-,10+,11+,13-,14-,15-/m1/s1"",BLUAFEHZUWYNDE-NNWCWBAJSA-N,";;
"Ligand,9889,RP-101075,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9889,Synthetic organic,,,,,52938426,363894183,N#Cc1cc(ccc1OC(C)C)c1onc(n1)c1cccc2c1CC[C@@H]2N,""InChI=1S/C21H20N4O2/c1-12(2)26-19-9-6-13(10-14(19)11-22)21-24-20(25-27-21)17-5-3-4-16-15(17)7-8-18(16)23/h3-6,9-10,12,18H,7-8,23H2,1-2H3/t18-/m0/s1"",WGUXQKIWMYYPQI-SFHVURJKSA-N,";;
"Ligand,11087,emetine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11087,Natural product,,,,,10219,434122148,CC[C@H]1CN2CCc3c([C@@H]2C[C@@H]1C[C@H]1NCCc2c1cc(OC)c(c2)OC)cc(c(c3)OC)OC,""InChI=1S/C29H40N2O4/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24/h13-16,18,21,24-25,30H,6-12,17H2,1-5H3/t18-,21-,24+,25-/m0/s1"",AUVVAXYIELKVAI-CKBKHPSWSA-N,";;
"Ligand,9844,CH-4051,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9844,Synthetic organic,,,,,11532464,363894138,OC(=O)[C@@H](NC(=O)c1ccc(cc1)CCc1ccc2c(c1)c(N)nc(n2)N)CC(=C)C(=O)O,""InChI=1S/C23H23N5O5/c1-12(21(30)31)10-18(22(32)33)26-20(29)15-7-4-13(5-8-15)2-3-14-6-9-17-16(11-14)19(24)28-23(25)27-17/h4-9,11,18H,1-3,10H2,(H,26,29)(H,30,31)(H,32,33)(H4,24,25,27,28)/t18-/m0/s1"",NAWXUBYGYWOOIX-SFHVURJKSA-N,";;
"Ligand,10027,cycloguanil,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10027,Synthetic organic,Antimalarial ligands,,,,9049,375973215,Clc1ccc(cc1)N1C(=NC(=NC1(C)C)N)N,""InChI=1S/C11H14ClN5/c1-11(2)16-9(13)15-10(14)17(11)8-5-3-7(12)4-6-8/h3-6H,1-2H3,(H4,13,14,15,16)"",QMNFFXRFOJIOKZ-UHFFFAOYSA-N,";;
"Ligand,2856,dihydrotestosterone,DHT,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2856,Metabolite,,,,,10635,135651474,O=C1CC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C)C,""InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1"",NVKAWKQGWWIWPM-ABEVXSGRSA-N,";;
"Ligand,2662,fenofibric acid,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2662,Synthetic organic,,,,,64929,135650256,Clc1ccc(cc1)C(=O)c1ccc(cc1)OC(C(=O)O)(C)C,""InChI=1S/C17H15ClO4/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11/h3-10H,1-2H3,(H,20,21)"",MQOBSOSZFYZQOK-UHFFFAOYSA-N,";;
"Ligand,7359,p-hydroxyatorvastatin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7359,Synthetic organic,,,,,9851106,178103931,O[C@@H](C[C@H](CC(=O)O)O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccc(cc1)O,""InChI=1S/C33H35FN2O6/c1-20(2)31-30(33(42)35-24-12-14-25(37)15-13-24)29(21-6-4-3-5-7-21)32(22-8-10-23(34)11-9-22)36(31)17-16-26(38)18-27(39)19-28(40)41/h3-15,20,26-27,37-39H,16-19H2,1-2H3,(H,35,42)(H,40,41)/t26-,27-/m1/s1"",SOZOATLLFFVAPM-KAYWLYCHSA-N,";;
"Ligand,11737,temocaprilat,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11737,Synthetic organic,,,,,443151,458923772,C1[C@H](SC[C@@H](C(=O)N1CC(=O)O)N[C@@H](CCc1ccccc1)C(=O)O)c1cccs1,""InChI=1S/C21H24N2O5S2/c24-19(25)12-23-11-18(17-7-4-10-29-17)30-13-16(20(23)26)22-15(21(27)28)9-8-14-5-2-1-3-6-14/h1-7,10,15-16,18,22H,8-9,11-13H2,(H,24,25)(H,27,28)/t15-,16-,18-/m0/s1"",KZVWEOXAPZXAFB-BQFCYCMXSA-N,";;
"Ligand,11556,brincidofovir,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11556,Synthetic organic,,,,,483477,441604928,CCCCCCCCCCCCCCCCOCCCOP(=O)(CO[C@@H](Cn1ccc(nc1=O)N)CO)O,""InChI=1S/C27H52N3O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-35-20-16-21-37-38(33,34)24-36-25(23-31)22-30-18-17-26(28)29-27(30)32/h17-18,25,31H,2-16,19-24H2,1H3,(H,33,34)(H2,28,29,32)/t25-/m0/s1"",WXJFKKQWPMNTIM-VWLOTQADSA-N,";;
"Ligand,11580,AZ5104,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11580,Synthetic organic,,,,,71496460,441604952,C=CC(=O)Nc1cc(Nc2nccc(n2)c2c[nH]c3c2cccc3)c(cc1N(CCN(C)C)C)OC,""InChI=1S/C27H31N7O2/c1-6-26(35)30-22-15-23(25(36-5)16-24(22)34(4)14-13-33(2)3)32-27-28-12-11-21(31-27)19-17-29-20-10-8-7-9-18(19)20/h6-12,15-17,29H,1,13-14H2,2-5H3,(H,30,35)(H,28,31,32)"",IQNVEOMHJHBNHC-UHFFFAOYSA-N,";;
"Ligand,9955,artemether,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9955,Natural product,Antimalarial ligands,,,,68911,374883842,CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@@H]4[C@]2([C@H]([C@H]1C)CC[C@H]4C)OO3,""InChI=1S/C16H26O5/c1-9-5-6-12-10(2)13(17-4)18-14-16(12)11(9)7-8-15(3,19-14)20-21-16/h9-14H,5-8H2,1-4H3/t9-,10-,11+,12+,13+,14-,15-,16-/m1/s1"",SXYIRMFQILZOAM-HVNFFKDJSA-N,";;
"Ligand,8308,dasotraline,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8308,Synthetic organic,,,,,9947999,252166520,N[C@@H]1CC[C@H](c2c1cccc2)c1ccc(c(c1)Cl)Cl,""InChI=1S/C16H15Cl2N/c17-14-7-5-10(9-15(14)18)11-6-8-16(19)13-4-2-1-3-12(11)13/h1-5,7,9,11,16H,6,8,19H2/t11-,16+/m0/s1"",SRPXSILJHWNFMK-MEDUHNTESA-N,";;
"Ligand,8096,BIBF-1202,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8096,Synthetic organic,,,,,11606145,249565776,CN1CCN(CC1)CC(=O)N(c1ccc(cc1)N/C(=C/1\C(=O)Nc2c1ccc(c2)C(=O)O)/c1ccccc1)C,""InChI=1S/C30H31N5O4/c1-33-14-16-35(17-15-33)19-26(36)34(2)23-11-9-22(10-12-23)31-28(20-6-4-3-5-7-20)27-24-13-8-21(30(38)39)18-25(24)32-29(27)37/h3-13,18,31H,14-17,19H2,1-2H3,(H,32,37)(H,38,39)/b28-27-"",KEHNCEDHZGQSNP-DQSJHHFOSA-N,";;
"Ligand,7688,AR-H067637,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7688,Synthetic organic,,,,,9811290,223366023,FC(Oc1cc(Cl)cc(c1)[C@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(cc1)C(=N)N)O)F,""InChI=1S/C21H21ClF2N4O4/c22-14-7-13(8-15(9-14)32-21(23)24)17(29)20(31)28-6-5-16(28)19(30)27-10-11-1-3-12(4-2-11)18(25)26/h1-4,7-9,16-17,21,29H,5-6,10H2,(H3,25,26)(H,27,30)/t16-,17+/m0/s1"",QTUUCFVBSVJGOH-DLBZAZTESA-N,";;
"Ligand,1347,6-hydroxymelatonin,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1347,Synthetic organic,,,,,1864,135649850,COc1cc2c(CCNC(=O)C)c[nH]c2cc1O,""InChI=1S/C13H16N2O3/c1-8(16)14-4-3-9-7-15-11-6-12(17)13(18-2)5-10(9)11/h5-7,15,17H,3-4H2,1-2H3,(H,14,16)"",OMYMRCXOJJZYKE-UHFFFAOYSA-N,";;
"Ligand,1935,misoprostol (free acid form),,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1935,Synthetic organic,,,,,6436406,135650610,CCCCC(C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)(O)C,""InChI=1S/C21H36O5/c1-3-4-13-21(2,26)14-9-11-17-16(18(22)15-19(17)23)10-7-5-6-8-12-20(24)25/h9,11,16-17,19,23,26H,3-8,10,12-15H2,1-2H3,(H,24,25)/b11-9+/t16-,17-,19-,21?/m1/s1"",CNWGPXZGIIOYDL-MKYGPDKMSA-N,";;
"Ligand,7321,venlafaxine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7321,Synthetic organic,,,,,5656,178103894,COc1ccc(cc1)C(C1(O)CCCCC1)CN(C)C,""InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3"",PNVNVHUZROJLTJ-UHFFFAOYSA-N,";;
"Ligand,10070,aprocitentan,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10070,Synthetic organic,,,,,25099191,375973257,Brc1ccc(cc1)c1c(OCCOc2ncc(cn2)Br)ncnc1NS(=O)(=O)N,""InChI=1S/C16H14Br2N6O4S/c17-11-3-1-10(2-4-11)13-14(24-29(19,25)26)22-9-23-15(13)27-5-6-28-16-20-7-12(18)8-21-16/h1-4,7-9H,5-6H2,(H2,19,25,26)(H,22,23,24)"",DKULOVKANLVDEA-UHFFFAOYSA-N,";;
"Ligand,5507,cyclohexylamine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5507,Synthetic organic,,,,,7965,178102153,NC1CCCCC1,""InChI=1S/C6H13N/c7-6-4-2-1-3-5-6/h6H,1-5,7H2"",PAFZNILMFXTMIY-UHFFFAOYSA-N,";;
"Ligand,9491,amiselimod phosphate,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9491,Synthetic organic,,,,,57704582,329968431,CCCCCCCOc1ccc(cc1C(F)(F)F)CC[C@](COP(=O)(O)O)(CO)N,""InChI=1S/C19H31F3NO6P/c1-2-3-4-5-6-11-28-17-8-7-15(12-16(17)19(20,21)22)9-10-18(23,13-24)14-29-30(25,26)27/h7-8,12,24H,2-6,9-11,13-14,23H2,1H3,(H2,25,26,27)/t18-/m1/s1"",OFRUGVQKZMGHHH-GOSISDBHSA-N,";;
"Ligand,2454,NN-dimethyl-D-erythrosphingosine,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2454,Metabolite,,,,,6438166,135650729,CCCCCCCCCCCCC/C=C/[C@@H]([C@H](N(C)C)CO)O,""InChI=1S/C20H41NO2/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)19(18-22)21(2)3/h16-17,19-20,22-23H,4-15,18H2,1-3H3/b17-16+/t19-,20+/m1/s1"",YRXOQXUDKDCXME-QWKHPXNBSA-N,";;
Ligand,8298,idarucizumab,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8298,Antibody,,,,,,252166510,,,,;;
"Ligand,2957,atorvastatin lactone,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2957,Synthetic organic,,,,,6483036,135649818,O[C@@H]1C[C@@H](CCn2c(C(C)C)c(c(c2c2ccc(cc2)F)c2ccccc2)C(=O)Nc2ccccc2)OC(=O)C1,""InChI=1S/C33H33FN2O4/c1-21(2)31-30(33(39)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-27-19-26(37)20-28(38)40-27/h3-16,21,26-27,37H,17-20H2,1-2H3,(H,35,39)/t26-,27-/m1/s1"",OUCSEDFVYPBLLF-KAYWLYCHSA-N,";;
"Ligand,6154,BIIL 260,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6154,Synthetic organic,,,,,9956189,178102775,Oc1ccc(cc1)C(c1ccc(cc1)OCc1cccc(c1)COc1ccc(cc1)C(=N)N)(C)C,""InChI=1S/C30H30N2O3/c1-30(2,24-8-12-26(33)13-9-24)25-10-16-28(17-11-25)35-20-22-5-3-4-21(18-22)19-34-27-14-6-23(7-15-27)29(31)32/h3-18,33H,19-20H2,1-2H3,(H3,31,32)"",MBLJFKQACMILLC-UHFFFAOYSA-N,";;
"Ligand,9052,dextrorphan,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9052,Synthetic organic,,,,,5360697,315661137,Oc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C,""InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m1/s1"",JAQUASYNZVUNQP-PVAVHDDUSA-N,";;
Target,3144,N-acetyltransferase 8 like,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3144,Enzyme,2.3.1.-  Acyltransferases,Human:Q8N9F0|Mouse:Q3UGX3,Human:NAT8L|Mouse:Nat8l|Rat:Nat8l,Human:26742|Mouse:MGI:2447776|Rat:1305719,,,,,,;;
"Family,267,""CYP24, CYP26 and CYP27 families"",,,http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=267,Enzyme,,,,,,,,,,";;
Family,135,Lysophospholipid (S1P) receptors,,,http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=135,GPCR,,,,,,,,,,;;
Family,1055,Isoprenoid biosynthesis enzymes ,,,http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=1055,OtherProtein,,,,,,,,,,;;
Family,783,Fatty acid-binding proteins,,,http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=783,OtherProtein,,,,,,,,,,;;
Family,243,Eicosanoid turnover,,,http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=243,Enzyme,,,,,,,,,,;;
Family,66,Vasopressin and oxytocin receptors,,,http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=66,GPCR,,,,,,,,,,;;
Family,121,Connexins and Pannexins,,,http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=121,OtherIC,,,,,,,,,,;;
Family introduction,35,Leukotriene receptors,,,http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=35,GPCR,,,,,,,,,,;;
Family introduction,88,1F. Retinoic acid-related orphans,,,http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=88,NHR,,,,,,,,,,;;
Family introduction,5,Complement peptide receptors,,,http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=5,GPCR,,,,,,,,,,;;
Family introduction,52,P2Y receptors,,,http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=52,GPCR,,,,,,,,,,;;
Target,1443,Cystathionine &beta;-synthase,CBS,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1443,Enzyme,Hydrogen sulphide synthesis,Human:P35520|Mouse:Q91WT9|Rat:P32232,Human:CBS|Mouse:Cbs|Rat:Cbs,Human:1550|Mouse:MGI:88285|Rat:2287,,,,,,;
Family,696,Voltage-gated ion channels,,,http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=696,Ic,,,,,,,,,,;;
Target,3085,nudix hydrolase 7,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3085,Enzyme,Hydrolases,Human:P0C024|Mouse:Q99P30,Human:NUDT7|Mouse:Nudt7|Rat:Nudt7,Human:8054|Mouse:MGI:1914778|Rat:1306719,,,,,,;;
Target,3102,dihydropyrimidine dehydrogenase,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3102,Enzyme,Nucleotide turnover,Human:Q12882|Mouse:Q8CHR6|Rat:O89000,Human:DPYD|Mouse:Dpyd|Rat:Dpyd,Human:3012|Mouse:MGI:2139667|Rat:621218,,,,,,;;
Target,3070,&alpha;&beta;-Hydrolase 12,ABHD12,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3070,Enzyme,2-Acylglycerol ester turnover,Human:Q8N2K0|Mouse:Q99LR1|Rat:Q6AYT7,Human:ABHD12|Mouse:Abhd12|Rat:Abhd12,Human:15868|Mouse:MGI:1923442|Rat:1562570,,,,,,
Target,190,ADGRF1,,,http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=190,GPCR,Adhesion Class GPCRs,Human:Q5T601|Mouse:Q8VEC3,Human:ADGRF1|Mouse:Adgrf1|Rat:Adgrf1,Human:18990|Mouse:MGI:1924846|Rat:1310285,,,,,,;;
